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Delivery of neurotrophic factor gradients offers exciting potential for improving 
the regenerative outcomes in peripheral nerve injuries by enhancing the complete 
regeneration of nerves across large injury gaps. However, a major limitation to current 
gradient generation platforms has been the inability to develop gradient generation 
methodologies that exhibit control of gradient characteristics suitable for in vitro gradient 
screening while also being scalable to length scales relevant for in vivo nerve regeneration 
paradigms. Few studies have reported the influence of NF gradients on Schwann cell 
migration. We developed two gradient generation platforms capable of highly controlled, 
centimeter-scale gradient generation, which are capable of gradient delivery in both in vitro 
and in vivo gradient guidance paradigms. Furthermore, we developed a novel combinatorial 
cell migration platform, which combines topographical and biochemical guidance to 
investigate the effect of surface topography and gradient characteristics on the guidance of 
human Schwann cells. Using a live-cell imaging and analysis platform, we elucidated 
extensive details of the influence of these cues on the migration kinetics of Schwann cells, 
examining the roles of aligned fiber diameter and NF gradient characteristics in directing 
Schwann cell migration. Finally, we created a nerve guide that combines topographical and 
biochemical gradient guidance and demonstrated the utility of NF gradient delivery in 
enhancing regeneration in acute, short gap and long-term, large gap in vivo peripheral nerve 
injury models. The advances in gradient generation and delivery presented in this thesis 
offer new platforms for characterizing gradient guidance of a variety of neuronal and glial 
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Chapter 1 : Tissue engineering and peripheral nerve 
regeneration: utilizing engineering principles to enhance nerve 
regeneration         
 Introduction 
1.1.1 Tissue Engineering 
There is a story in Greek mythology about a Titan named Prometheus, who 
betrayed the Greek god Zeus. As punishment, Prometheus was chained to the top of a 
mountain where, every day, an eagle would consume his liver. However, due to 
Prometheus’ immortality, he would survive and the liver would regenerate every night, and 
thus his punishment would continue day after day. For thousands of years, mankind has 
envisioned the ability for humans to regenerate our organs and tissues and heal wounds 
beyond the capacity for the human body to normally regenerate. 
The practice of tissue engineering, utilizing knowledge of the structure and function 
of mammalian tissues to design biological substitutes for the repair of irreparably damaged 
organs and tissues, first arose in the mid-20th century [1]. However, it was not until 1988 
that the field of “tissue engineering” was clearly defined, formally establishing an exciting 
field of academic pursuit and ushering in an era of increased research and development in 
the tissue engineering and regenerative medicine (TERM) fields. Since the first publication 
in the journal Tissue Engineering in 1995 [1], the field has rapidly expanded in breadth, 
encompassing research in the repair and replacement of all nearly all organs and tissues. 
From January 2012 to September 2013 alone, there were 8000 publications in the TERM 
fields [2], an incredible demonstration of the amount of effort that researchers are putting 
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into this rapidly advancing field. Elite research universities around the world have 
established academic centers with the expressed purpose of conducting TERM research, 
including the Translational Tissue Engineering Center at Johns Hopkins University, 
demonstrating the importance of TERM research in the future of modern medicine.  
With the continued advancement in development of biologically-active materials 
and scaffolds and obtaining patient-specific cells which circumvent issues with tissue 
rejection typically seen in allogeneic organ transplants, the tools for modifying or creating 
tissues has increased exponentially since the TERM fields were first established [2, 3]. 
However, regulatory hurdles and safety concerns continue to hinder the clinical application 
of more recent technologies [3]. As researchers continue their efforts to improve our 
understanding of human biology, physiological development, and how human bodies 
respond and adapt to injury, the safety and efficacy of the latest TERM technologies will 
continue to improve. Considerable effort has been placed on the production of materials 
which mimic the form and function of mammalian tissues, recreating or redesigning the 
extracellular milieu of tissue-specific cells to control the migration and phenotypic function 
of these cells into organized, 3-dimensional engineered tissues for drug testing or tissue 
replacement as alternatives to organ transplantation. Engineered tissue scaffolds can be 
designed to mimic the biochemical and structural composition of their native tissues, and 
technologies for building these tissue scaffolds into complex, 3-D, hierarchical structures 
continues to advance. Through advancing our understanding of how native tissues are 
formed during development and the relationship between tissue structure and function, the 
TERM fields are constantly edging closer to being able to safely and effectively recreate 
or enhance the regeneration of damaged tissues and improve the lives of countless patients 
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suffering from disease and trauma for which current clinical practice has limited 
regenerative potential. 
1.1.2 Peripheral nerve regeneration 
Peripheral nerve injuries are a major cause of loss of limb function in patients 
worldwide, with nerve injuries occurring in 2.8% of traumatic injuries [4]. In the United 
States alone, approximately 360,000 people suffer from various forms of upper body 
paralysis on an annual basis [5]. The preferred surgical treatment is end-to-end 
anastomosis, but for injuries which produce a large gap in a nerve, the clinical gold standard 
is to use an autologous nerve graft. However, autologous nerve grafts have several major 
drawbacks limiting their use and efficacy, including donor site morbidity, motor/sensory 
nerve mismatch, neuroma formation, size restrictions, and limitation in functional 
regeneration [6]. Alternative FDA-approved products are available for applications in 
which large gap injuries occur, but the lack of directional guidance in these products limits 
their regenerative capacity, especially as gap size increases [7]. Newer approaches to nerve 
regeneration aiming to overcome the limitations of current clinically-available nerve 
regeneration methods utilize strategies ranging from biomaterials engineering to cell-based 
therapies, incorporating endogenous or exogenous sources of cells, extracellular scaffolds, 
or biochemical cues to enhance the regeneration of injured nerves [8]. Our lab is currently 
investigating methods for enhancing nerve regeneration through the design of nerve 
guidance conduits (NGCs) containing topographical and biochemical guidance, and 
delivery of genetically-modified glial or stem cells to the site of nerve injury (Figure 1.1). 
By using a combinatorial NGC incorporating nanofiber-based topographical guidance and 
biochemical gradients of neurotrophic factors to promote growth across the entirety of a 
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large nerve gap, we intend to improve nerve regeneration beyond levels achievable by 
current clinical standards. 
1.1.3 Biochemical cues in nerve tissue development and applications in nerve 
regeneration 
The human body provides tissue engineers a near limitless toolbox of biochemical 
cues consisting of growth factors, adhesive ligands, extracellular matrix proteins and 
peptides which guide human development, maintain the form and function of the body, and 
which are naturally produced after injury to promote regeneration. Many of the 
neurotrophic factors (NFs) which are effective in promoting regeneration in the adult 
mammals have primary roles in the development of the mammalian nervous system, 
providing selective differentiation of sympathetic, parasympathetic, cholinergic, 
adrenergic, dopaminergic, motor, and sensory neurons [9]. Cordes summarized many of 
the genes and proteins involved in the development of mouse cranial nerves and sensory 
ganglia and categorized the genes and proteins based on function within the developing 
nervous system and emphasized the specificity of their activity for specific nerve 
populations [9]. Many of these genes and proteins have significant roles in the development 
of both the central and peripheral nervous systems and have been investigated to enhance 
regeneration of injuries in the central and peripheral nervous systems. 
A subpopulation of proteins, collectively known neurotrophic factors, are of 
particular interest in nerve regeneration due to their characteristic activity promoting 
neuron survival, growth, and in some cases neuronal chemotaxis. Of the neurotrophin 
family of neurotrophic factors, nerve growth factor (NGF) is the most studied and is known 
to act specifically on small primary sensory and sympathetic neurons [10]. The effects of 
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NGF were first discovered by Elmer Bueker, who demonstrated that fragments of mouse 
sarcoma grafted in the body of three-day chick embryos promoted sensory nerve fibers to 
infiltrate the tumor from dorsal root ganglia adjacent to the tumor [11]. In normal nerves, 
NGF is expressed at similar levels in motor and sensory neurons, but following injury NGF 
expression is substantially upregulated in denervated sensory roots compared to levels 
expressed in denervated motor roots [12]. Herrup demonstrated that administration of NGF 
to chick dorsal ganglia promote upregulation of NGF receptors [13], indicating a potential 
feedback loop following an injury where NGF upregulation results in increased expression 
of NGF receptor and changes in sensitivity towards the growth factor. Whereas NGF has 
substantial effects on growth and survival of embryonic sensory neurons, the effect 
decreases in adult large sensory neurons [14] but is necessary for collateral sprouting of 
nociceptive and sympathetic axons into denervated skin [14, 15]. NGF has been shown to 
promote chemotaxis of sympathetic [16], dorsal root ganglion neurons [17-20], and PC12 
neurons [21, 22], and increases Schwann cell migration from nerve explants [23]. 
Additionally, NGF has been utilized to enhance regeneration of peripheral nerve injuries 
via controlled release in nerve guidance conduits [24-30], osmotic pump [31, 32], or 
lentiviral-based overexpression [33, 34]. However, due to the specificity of NGF towards 
sensory and sympathetic neurons, the potential for use as a suitable growth factor for 
enhancing regeneration of mixed nerve populations (i.e. motor and sensory), commonly 
found in peripheral nerve injuries, is limited due to the limited trophic activity of NGF 
towards motor neurons. 
Brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) are members 
of the neurotrophin family which possess greater motor neuron trophic potential. BDNF is 
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expressed in uninjured motor and sensory neurons, but is primarily upregulated in sensory 
neurons following injury [12] and in Schwann cells in the distal stump of an injury [35]. 
The result by Höke et. al. showing greater upregulation in injured sensory neurons 
compared to injured motor neurons [12] is interesting considering the general role of BDNF 
and dose-dependent response on motor neuron survival and growth [35], but its 
upregulation in the distal stump of motor neuron-containing injuries is indicative of its 
influence on motor neuron survival and regeneration. NT-3 is expressed in adult skeletal 
muscle and exhibits a trophic role on motoneurons in vitro [36] and type 2b fast muscle 
fiber associated neurons [37], but has also been shown to enhance the survival of 
proprioceptive and mechano-receptive sensory neurons [38, 39]. Expression of NT-3 is 
generally higher in sensory roots compared to motor roots but have minimal difference in 
expression after injury [12]. 
Neuregulins (NRGs) are derived from alternative splicings of the NRG1 gene and 
consist of 14 separate protein variations [40]. NRGs elicit substantial influence of Schwann 
cell activity directed by cell-cell interactions with axons, which express both soluble and 
membrane-bound variants [40]. One of the most widely studied neuregulins is the glial 
growth factor (GGF), which is a soluble, paracrine signaling isoform of NRG expressed by 
sensory, motor and sympathetic neurons [41, 42]. GGF has pronounced effects on Schwann 
cells, as demonstrated by Mahanthappa et. al. who showed delivery of soluble GGF2 
increased Schwann cell migration from sciatic nerve cryosections [43]. GGF expression is 
upregulated in damaged sensory neurons and coincides with a coordinated upregulation of 
its receptor in Schwann cells, indicating coordination in NRG regulation in Schwann cells 
and axons following nerve injury [44, 45]. While NRG largely effects Schwann cell 
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activity, NRGs are expressed by axons and Schwann cells and act via autocrine or paracrine 
mechanisms [40, 45]. 
Glial-derived neurotrophic factor (GDNF) is an increasingly studied neurotrophic 
factor of the TGFα-1 superfamily, and has trophic effects on sensory, motor and autonomic 
neurons [46-52]. Overexpression of GDNF in the central nervous system promotes 
dramatic survival of motor neurons after axotomy [53]. Additionally, GDNF has been 
shown to be a potent chemotactic agent and binding ligand for Schwann cell precursors 
[54], providing strong trophic activity to both neurons and glial cells in the central and 
peripheral nervous system. GDNF is upregulated in both motor and sensory neurons 
following nerve injury [12] which subsequently upregulates the GDNF receptor [55], 
indicating its important role in neurotrophic support in both motor and sensory neuron 
populations. Comparison of the recovery of sciatic nerve injury following release of GDNF 
or NGF by synthetic nerve guidance conduit revealed significantly higher regeneration of 
both motor and sensory neurons using sustained GDNF delivery compared with NGF 
delivery [30], indicating greater regenerative potential of GDNF compared to widely-
studied NGF. Furthermore, GDNF plays an important role in myelination by inducing 
Schwann cell proliferation and axon myelination, and is even capable of promoting 
myelination of axons which are normally unmyelinated [56]. The significant trophic effect 
of GDNF and its ability to mediate axon-glial interactions made GDNF the primary 
neurotrophic factor of interest for the studies involved in this thesis, investigating novel 
methodologies for delivering GDNF which will maximize its influence in enhancing 
peripheral nerve regeneration. 
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1.1.4 Anisotropy and overcoming the “candy store” effect 
Although delivery of GDNF has been shown to improve the nerve regeneration 
potential of nerve guidance conduits by improving motor and sensory neuron survival and 
outgrowth, delivery of locally elevated levels of GDNF causes an axon trapping effect 
known as the “candy store” effect [57]. Axons are attracted to locations of high GDNF 
concentration, and maintenance of persistent levels of GDNF causes trapping of 
regenerating axons at the site of overexpression, preventing axons from migrating distally 
to their muscle and sensory targets [33, 58]. Several studies have demonstrated a 
neurotropic effect of GDNF, in which axons preferentially migrate towards regions of 
maximum GDNF expression and concentration [59, 60]. Similar effects have been elicited 
by lentiviral overexpression of BDNF [61] and NT-3 [62]. While the chemotropic effect of 
NFs can be utilized to guide nerve outgrowth, careful consideration must be made in 
designing a NF delivery method which is capable of harnessing the chemotropic capability 
of neurons without hindering their progression towards their reinnervation targets. One 
method of circumventing the axonal trapping effect is by expressing GDNF in the target 
muscle rather than at the injury site, a method which has been shown to enhance functional 
regeneration in a mouse crush injury model [63]. While promising, the positive effects of 
target-derived expression may be limited to injuries which are located close to the target 
site. For injuries in which the neurons must traverse large distances to reach the target 
muscle or sensory input, the likelihood for NFs expressed at the target site to diffuse to and 
reach the regenerating neurons may be severely limited. For injuries which are located 
large distances from innervation targets, localized delivery of NFs remains to be the most 
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effective method for promoting nerve regeneration through a nerve injury and into the 
distal nerve.  
Recently, a promising method for delivering localized GDNF in a temporally-
controlled manner was developed by Marquardt et. al.. By transfecting Schwann cells with 
a tetracycline-inducible GDNF lentivirus and injecting the transfected Schwann cells into 
the distal nerve of a 3 cm sciatic nerve defect bridged by fibrin-modified acellular nerve 
grafts, they were able to modify the duration of GDNF overexpression based on the 
duration of doxycycline administration and control release of GDNF using an affinity-
based release system. They found that 6 weeks of overexpression produced the greatest 
regenerative outcome compared to 4 or 8 week overexpression, exhibiting the greatest 
axonal regrowth in the midgraft and distal nerve and promoting the greatest mass recovery 
of target muscle. The study provided excellent insight into the importance developing a 
platform which provides temporal control of GDNF delivery to enhance regeneration 
across an injury gap while preventing the excessive localized GDNF overexpression that 
results in decreased functional recovery due to the “candy store” effect. However, 
tetracycline-inducible GDNF expression provides limited control over precise GDNF 
concentration levels, resulting in potentially sub-optimal GDNF expression levels and 
difficulty in controlling the spatial distribution of GDNF across the injury site. 
Additionally, the requirement for lentivirus-transfected, exogenous Schwann cells limits 
the potential for this method to be developed as an off-the-shelf product and reduces its 
potential clinical use. 
Controlled-release methods which deliver NFs by administration of NF-loaded 
microspheres [60, 64-66], polymeric films [30], lipid microtubules [26], nanofibers [67], 
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and crosslinked [27] or affinity-based hydrogels [68] can overcome the limitations of 
lentivirus-based NF overexpression by providing improved spatial and temporal control of 
NF delivery. With these methods, nerve guidance conduits can be designed to specific 
lengths and conduit diameter depending on the location and size of the injury and loaded 
with a variety of NFs at specified concentrations. The ability to manufacture nerve 
guidance conduits containing these controlled release platforms improves their potential 
for development of off-the-shelf products for clinical applications compared to 
transfection-based platforms.  
Effective nerve regeneration requires not only the promotion of the axonal 
outgrowth, but also directional guidance of the regenerating axons towards the target site. 
Methods of guiding axons within the NGC have thus been employed to promote directional 
regrowth. A study by Parrinello et al. revealed that Ephrin signaling between fibroblasts 
and dedifferentiated and migrating Schwann cell progenitors is important in forming cords 
of Schwann cells, akin to the Bands of Büngner in vivo, which then serve as regenerating 
tracks guiding axonal regrowth [69]. This process can be recreated in vitro by generating 
Ephrin-B2 bands on growth matrix that organize Schwann cells into a band-like structure. 
Such directional guidance promoted axonal growth along the Schwann cell bands [69]. 
This strategy can certainly be adopted in NGC design to enhance the ability of Schwann 
cells to organize into Bands of Büngner, therefore enhancing directional axon regrowth. 
Gradients of NFs and adhesive molecules have also been employed in NGCs due to their 
ability to promote directional axonal growth and their enhancement of nerve regeneration 
and function compared to isotropic concentrations of similar molecules [26]. Dodla et al. 
incorporated gradients of nerve growth factor (NGF) and laminin into a NGC and 
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compared the results of various combinations of NGCs containing isotropic concentrations 
of the two signaling molecules or combinations of isotropic and anisotropic concentrations. 
They found that functional recovery was significantly higher in the NGCs containing 
gradients of both laminin and NGF when compared to those containing isotropic 
concentrations of the two molecules [26]. Although the author did not include data for axon 
length, number, and myelination for the isotropic NGCs, the significant difference in 
functional recovery between isotropic and anisotropic NGCs demonstrates that gradients 
of NFs and adhesive molecules provide greater ability to promote axon regrowth across the 
lesion than their isotropic counterparts. Moreover, the gradient approach is capable of 
providing directional cues along the entire length of the lesion, both promoting growth 
from the proximal stump to the distal stump and allowing axons to grow into the distal 
stump and target tissue. The latter is of particular importance to avoid axonal entrapment 
within the NGC caused by the “candy store” effect. 
The simple incorporation of a gradient does not necessarily ensure maximal 
regenerative capacity. Mortimer et al. created a model to predict the response of neurites 
to varying concentrations and gradients of NGFs. Their model predicted that both the 
gradient steepness and concentration range determine the regenerative capability of a NF 
gradient, a prediction confirmed by culturing DRG explants on collagen sheets printed with 
different NGF gradient concentration ranges and steepnesses [19]. Not only does this paper 
demonstrate the importance of multiple variables of a NF gradient, but it also provides a 
means to better predict the optimal conditions with which to develop and apply a NF 
gradient to a NGC. In addition, variation in nerve response to gradients depends upon the 
location of the injury [70], and the type of nerve can determine which NFs may provide 
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the greatest regeneration effect [12, 71]. This characteristic of NFs enables high specificity 
in nerve regeneration by selecting NF cocktails tailored for a particular nerve type. This 
approach may be advantageous to regenerate the desired nerve type and function and avoid 
formation of undesired nerve connections. Therefore, NF gradients provide an effective 
approach to improve the speed and directionality of nerve regrowth, which can synergize 
well with other nerve regeneration approaches. 
 Hypothesis and Specific Aims of the Thesis 
 Current gradient generation platforms are limited by the length of gradients which 
can be produced, lack of scalability, and poor control of gradient characteristics. Many 
gradient methods are specialized for the study of cell migration in gradients of short length 
scales (<1 mm), or limited to long-range (>1 cm) length scales due to limited control of 
gradient production and can only be used in large gap nerve injury models. The significant 
discrepancies in the scale at which current gradient can be produced results in the inability 
to develop in vitro gradient guidance platforms for screening NF gradients and gradient 
conditions for their efficacy in guiding neuronal and Schwann cell outgrowth which can be 
easily translated to in vivo gradient delivery platforms. To address this knowledge gap, we 
developed two unique gradient generation techniques, as described in Chapter 2. The first 
technique is a rapid, convection-driven method developed in collaboration with the 
Khademhosseini lab at MIT which is capable of generating NF gradients of tailorable 
concentration ranges and millimeter to centimeter length, which encapsulates the gradients 
in a UV-crosslinkable methacrylated gelatin hydrogel. This method allows for rapid, 
scalable production of gradients over a large range of length scales and is a suitable 
platform for use in in vitro neuron and Schwann cell migration guidance assays for the 
13 
 
screening of the effects of gradient characteristics on migration behavior. Additionally, the 
ability to generate gradients of multi-centimeter length scales allows for utilization of this 
method to generate gradients for implantation in nerve guidance conduits for critical gap 
nerve injury (>10 cm) regeneration. The second method we developed is a diffusion-based 
method capable of gradient generation at centimeter scales in cell culture environments and 
is capable of generating gradients in a variety of hydrogel film materials for in vitro and in 
vivo delivery. Our first hypothesis is the rapid convection-based method can be utilized to 
for in vitro migration guidance assays investigating both aligned nanofiber topographical 
guidance and can be easily translated into our combinatorial NGCs for in vivo peripheral 
nerve regeneration. Our second hypothesis is that the diffusion-based platform will be an 
ideal model for investigating the mechanisms underlying the response of Schwann cells 
and neurons in 2D and 3D in vitro culture platforms. 
After developing and characterizing the two gradient platforms, we found both 
gradient platforms exhibited excellent control over gradient characteristics and were able 
to utilize heparin conjugation to control the release of NFs from methacylated gelatin 
hydrogels. Hydrogels generated by the convection-based platform were then incorporated 
into a novel cell migration chamber which cultures cells on aligned nanofibers of 
controllable diameters and which delivers NF gradients via gradient-loaded methacrylated 
gelatin hydrogel. In Chapter 3, we used these novel gradient/nanofiber chambers and 
developed a live-cell imaging and analysis program to evaluate the migration of Schwann 
cells in response to fibers of different diameters, gradients of different NFs, and different 
gradient steepness and concentration range conditions. Our hypotheses are (1) that there 
exists an optimal fiber diameter upon which Schwann cell migration rate will be 
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maximized, (2) that gradients of GDNF, NGF, and NRG1 will elicit different migration 
behavior, and (3) that Schwann cell migration kinetics will differ depending on gradient 
concentration and steepness. 
While evaluating the migration response of Schwann cells in our combinatorial 
migration chambers, we found that Schwann cell migration rate was fastest on 1.2 µm 
diameter aligned fibers, GDNF elicited the strongest chemotactic response of the three NFs 
tested, and that both gradient steepness and concentration range were important 
characteristics in guiding Schwann cell directional migration in vitro. In Chapter 4, we 
evaluated the effect of GDNF gradient delivery in our combinatorial NGC in two in vivo 
models: (1) a 7-mm gap, rat sciatic nerve model which was used to evaluate the effect of 
gradient steepness on axonal growth and to select a gradient condition for the second 
model, (2) a canine peroneal nerve 20-mm gap model to evaluate the efficacy of GDNF 
gradient delivery in enhancing nerve regeneration across a critical nerve injury gap. We 
hypothesize that (1) gradient steepness is an important characteristic for enhancing in vivo 
nerve growth and (2) that delivery of GDNF as a gradient will enhance the regeneration of 
axons across a critical nerve injury gap and improve functional recovery compared to 
uniform GDNF delivery. 
The following specific aims were pursued in this thesis to test the aforementioned 
hypotheses. 
Aim 1 (Chapter 2): Develop platforms for generating/delivering diffusible NF 
gradients on 2D substrates and encapsulating gradients in 3D hydrogels as a gradient 
delivery vehicle for in vitro and in vivo cell migration and nerve regeneration. 
Two gradient generation techniques were developed: (1) rapid, scalable method for 
in vitro and in vivo gradient delivery, and (2) diffusion-based method for generation of 
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gradients in live-cell, 2D and 3D migration platforms. The rapid, convection-based method 
was modified to improve scalability and release kinetics were controlled via heparin-
conjugation. The diffusion-based platform was modeled using COMSOL and utility as a 
hydrogel-based gradient-loading method was established. 
Aim 2 (Chapter 3): Establish live-cell imaging and cell migration analysis platform 
for investigating effects of growth factor gradient delivery and topographical guidance on 
the migration guidance of Schwann cells. 
Schwann cell migration on aligned nanofibers and in response to gradients of 
GDNF, NGF, and NRG1 was tested in novel migration chambers. Live cell imaging and 
migration analysis was conducted to evaluate influence of nanofiber diameter and gradient 
characteristics on in vitro migration kinetics of Schwann cells. 
Aim 3 (Chapter 4): Evaluate efficacy of NF gradient delivery in small and large 
animal in vivo peripheral nerve injury models. 
GDNF gradients were incorporated into aligned nanofiber NGCs and evaluated for 
efficacy in improving in vivo peripheral nerve regeneration. Two gradient steepness 
conditions were evaluated for efficacy in an in vivo non-critical gap model to select most 
effective gradient for increasing axonal outgrowth. Gradient NGC was then tested in an in 
vivo critical gap defect model and evaluated for efficacy in improving axonal growth across 







Figure 1.1: Signaling cue presentation and cell-incorporation approaches to enhance nerve 
regeneration. NGC functionality can be enhanced by incorporating (a) topographical and 
adhesion signaling, (b) neurotrophic factor (NF) gradients, (c) Schwann cells over-
expressing NFs, and (d) adult stem cells such as mesenchymal stem cells (MSCs) and bone 
marrow-derived stromal cells (BMSCs). Figure reproduced by permission from Elsevier 
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Chapter 2 : Gradient Generation Platforms for In Vitro and In 
Vivo Neurotrophic Factor Delivery  
 Introduction 
The pioneering work of Paul Letourneau provided the first evidence that neurons 
exhibit a chemotactic response to NF gradients, developing the first platform for studying 
axonal extension under well-defined NGF gradient conditions [1]. The study was concrete 
evidence that axonal migration can be directed though control of NF presentation. Since 
that study, numerous methods have been developed to improve our understanding of 
neuronal chemotaxis in efforts to utilize NF gradient delivery as a method for enhancing 
central and peripheral nerve regeneration [2-29]. Microfluidics-based methods offer 
excellent control of gradient characteristics and provide insight into neuronal guidance in 
short-range (<1 cm) in vitro gradients [7, 17, 18, 20, 29, 30], but suffer from the inability 
to scale the method to centimeter length scales relevant to in vivo nerve applications. 
Surface-immobilized gradient techniques provide a greater potential range of gradient 
lengths, but suffer from limited control of gradient concentration and restrict the influence 
of gradient presentation to only cells in direct contact with the gradient-immobilized 
surface [3, 4, 7, 24, 30, 31]. Gradients formed by mixing of NFs into electrospun or 
extruded fibers are capable of establishing long-range (>1 cm) macroscopic gradients for 
in vivo application, but suffer from a lack of localized gradient control limiting their 
efficacy for investigating in vitro neuronal guidance in response to finely-tuned gradient 
conditions [25, 26, 28]. Printing-based methods offer adequate gradient control and a range 
of length scales suitable for in vitro and in vivo gradient applications, but gradients are 
rapidly diminished after printing and the requirement for specialized printing machines 
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limits the potential scalability of the platform [10, 19, 22]. The lack of scalable gradient-
generation techniques, which provide precision control of gradient characteristics and are 
capable of generation of stable centimeter-scale gradients has limited the advancement of 
our understanding of how localized gradient conditions effect macroscopic neuronal 
outgrowth on multi-centimeter scales. Furthermore, the limitations of current gradient 
generation platforms result in the specialization of the gradient generation techniques for 
either in vitro or in vivo-specific applications, limiting their capability to be utilized both 
as in vitro neuron guidance screening tools while being easily translated into in vivo nerve 
regeneration platforms. 
In this chapter, we discuss the development of multiple gradient generation 
techniques capable of generating gradients with tailorable and well-controlled gradient 
characteristics, which provide scalable gradient production and are capable of delivery of 
gradients in both in vitro and in vivo gradient guidance platforms. First, we developed a 
rapid, convection-driven gradient generation technique in collaboration with the Ali 
Khademhosseini lab [32, 33] which provided tailorable, scalable gradient generation 
immobilized in a crosslinked methacrylated gelatin hydrogel for controlled delivery in in 
vitro and in vivo gradient guidance assays. By modifying the channel dimensions and 
changing the hydrogel composition, we were able to establish a scalable, controllable 
gradient generation platform with tailorable gradient release kinetics. We then discuss the 
development of a diffusion-based microfluidics gradient generation method capable of 
generation of centimeter-scale gradients under cell-friendly conditions for 2D and 3D 
tissue cultures. With this platform, we demonstrate the ability to generate stable centimeter-
length gradients under shear-free conditions for high-throughput live-cell migration assays 
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in 2D and 3D culture conditions, which can be utilized for generating gradients in hydrogel 
films for in vitro and in vivo delivery. 
 Materials and Methods 
2.2.1 Methacrylated gelatin synthesis 
Methacrylated gelatin (MG) was prepared as described by Nichol et al. [33]. Type 
A porcine skin gelatin (Sigma) was dissolved in Dulbecco’s phosphate buffered saline 
(DPBS, Gibco) at 10% (w/v) and heated at 60°C until dissolved. The solution was then 
reduced to 50°C and 1 mL of methacrylic anhydride was slowly added to the gelatin slurry 
at 0.5 mL/min while being stirred. The solution was reacted for 1 hour, after which the 
solution was diluted 5× with DPBS warmed to 40°C to stop the reaction. The mixture was 
then dialyzed in distilled water in 12 – 14 kDa cutoff dialysis tubing at 4°C for one week, 
with the dialysis solution being replaced daily. After one week, the MG solution was 
distributed into 50 mL conical tubes, frozen at -20°C, transferred to -80°C, and lyophilized 
until dry. The tubes were then stored at -20°C until ready for use. 
2.2.2 Fabrication of microfluidic devices 
All microfluidic devices were fabricated using standard soft-lithography methods. 
Photomasks with channel patterns were designed using Microsoft PowerPoint and printed 
on transparencies at 10,000 dpi resolution (In Tandem Design, Baltimore, MD). Master 
molds were prepared at 100 µm thickness by patterning a negative photoresist (SU-8 2050) 
on a silicon wafer. PDMS molds were prepared by curing pre-polymer (Sylgard 184, 
Kreyden) on the silicon masters. PDMS molds were prepared using a 10:1 ratio of 
elastomer to curing agent. The PDMS prepolymer solution was poured on the silicon 
master and baked at 80°C for 2 hours. The PDMS molds were then peeled off the silicon 
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master, and inlet and outlet of the microchannels were created for each channel using a 1 
mm hole punch. Each microfluidic device consisted of a top PDMS channel and a bottom 
glass or TCPS slide or well. 
2.2.3 Convection and diffusion-based microfluidics gradient platform 
Gradients immobilized in MG were prepared by modifying the method originally 
described by Du et al. [32]. For gradient characterization, microfluidics channels of 100 
µm height, 4 mm width, and 4 cm length were used. MG was dissolved in PBS at 5% (w/v) 
with 0.5% (w/v) Irgacure 2959 and heated to 37°C. PDMS channels were placed on glass 
slides and placed in a petri dish containing a damp paper towel soaked in water and warmed 
to 37°C on a hot plate. The PDMS channel was filled with warmed MG solution. A 200-
µL droplet of MG was added to the outlet, and a 10-µL solution of MG containing the 
molecule of interest was added to the inlet. The petri dish was then covered and the 
gradients were allowed to generate for before crosslinking the MG using a UV lamp. After 
crosslinking, the channels were removed from the glass and the crosslinked gradient 
hydrogels were dried before use in in vitro or in vivo gradient delivery experiments. To 
characterize gradient formation, FITC-lysozyme was used as the molecule of interest in the 
inlet and gradients were visualized using a Typhoon Gel Reader. 
Further modifications to the method were later made to increase the gradient 
generation throughput by reducing the channel size to 8 mm length by 2 mm width by 100 
µm height and producing larger numbers of channels parallel to one another. Gradients 
were established similar to the method described above but using modified volumes of 100 
µL solution at the outlet and 2 µL at the inlet. The smaller channels were used for 
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establishing gradients for in vitro migration cultures and were characterized using FITC-
lysozyme fluorescent gradients visualized using a Typhoon Gel Reader. 
2.2.4 Controlled release of growth factor gradients 
Release studies were conducted by producing in 4 cm long MG hydrogels using the 
method described previously. Briefly, gradients of glial-derived neurotrophic factor 
(GDNF) were generated by loading 20 mg/mL GDNF in MG solution in the inlet, after 
which the gradients were immobilized in the MG by crosslinking the hydrogel with UV. 
Gradients were also prepared using GDNF co-loaded with methacrylated heparin 
(graciously provided by the Khademhosseini lab, Harvard-MIT) at 1:1 and 10:1 ratios of 
heparin to GDNF. All gels were dried and cut into 6 equal sized segments, with each 
segment being placed in separate wells of a 96 well plate, and 50 µL of PBS was added to 
each well. The 96 well plate was sealed with parafilm and placed in a 4°C refrigerator. On 
days 1, 3, 7, and 14, the PBS was collected and replaced. After the release study was 
finished, a GDNF ELISA (R&D Systems) was used to measure the release of GDNF. 
GDNF ELISA values were compared to standards as instructed in the ELISA kit and 
measured in a plate reader. 
2.2.5 Diffusion-based gradient generation platform 
A novel diffusion-based gradient platform was developed for determining the effect 
of establishing centimeter-scale gradients in the presence of cells. Channels were 
microfabricated with the dimensions of 0.1 mm (height) × 4 mm (width) × 10 mm (length). 
PDMS was polymerized at a thickness of 5 mm and wells were bored at each end of the 
channel using a 3 mm hole punch. To generate gradients, the channels were placed on glass 
or TCPS and filled with PBS or media. The “inlet” was then sealed with a thin wafer of 
31 
 
PDMS and the “outlet” was filled with PBS or media. The “outlet” was then sealed with a 
thin PDMS wafer, the “inlet” on the wafer removed, and the “inlet” was filled with PBS or 
media containing the molecule of interest. The “inlet” was then sealed with a PDMS wafer 
and the gradient allowed to establish for 4-24 hours depending on the molecular weight of 
the molecule of interest. Gradients were characterized by establishing a gradient of FITC-
lysozyme and imaged using a Typhoon Gel Reader. 
2.2.6 Hydrogel loading using diffusion-based gradient generation technique 
The diffusion-based platform described in 2.2.5 was modified to be able to 
encapsulate gradients in a large variety of hydrogel materials. Thin 500 µm PDMS films 
were polymerized between aluminum plates and cut into frames with outer dimensions of 
14 mm (length) × 8 mm (width) and inner frame dimensions of 10 mm (length) × 4 mm 
(width).  Hydrogel films of fibrin, collagen, MG, or hyaluronan-PEG were then 
polymerized in the frames to form 500-µm thick hydrogels films. For gradient 
characterization studies, collagen films were polymerized in the frames by mixing 8 parts 
chilled 10 mg/mL collagen type I, 1 part chilled 7.5% (w/v) sodium bicarbonate, and 1 part 
chilled 10× PBS, and pipetting the solution into separate frames before incubating at 37°C 
for one hour. The diffusion gradient channels were then placed over the hydrogel frame 
and gradients of FITC-lysozyme were established using the method described in section 
2.2.5. As gradients established in the channels, they diffused into the underlying hydrogel, 




2.2.7 Data analysis 
Gradient establishment in both methods was imaged using the Typhoon Gel Reader 
and fluorescence was analyzed using Image J. Fluorescence was compared against 
standards. Plots of GDNF release represent mean ± Standard Error.  
 Results and Discussion 
2.3.1 Microfluidics gradient characterization 
In order to generate centimeter-scale gradients encapsulated in hydrogel films for 
in vitro and in vivo delivery, we have adopted a technique developed previously by 
Khademhosseini et al. [32]. This technique allows for the rapid (one hour or shorter) 
generation of gradients of tailorable concentration ranges and length scales ranging from 
millimeters to centimeters using a single microfluidics channel which are encapsulated 
within UV-crosslinked methacrylated gelatin strips (Figure 2.1). In brief, the gradient 
generation platform consists of a single microfluidics channel with a single inlet at outlet 
at each end of the channel. The channel is filled with a UV-crosslinkable hydrogel 
precursor solution. A large volume of hydrogel precursor solution is pipetted onto the outlet 
and a small volume of hydrogel solution containing the molecule of interest is pipetted 
onto the inlet. The differences in solution volume at the outlet and inlet causes a differences 
in surface tension which causes the small droplet at the inlet to be driven into the channel 
via convection-based flow, establishing a gradient. As the gradient generation continues, 
diffusion and backflow caused by evaporation at the inlet further elongates the gradient, 
allowing for greater control over the gradient characteristics. Once the gradients have been 
generated, the channel contents are exposed to UV light to crosslink the hydrogel and 
encapsulate the gradient in a hydrogel strip. The hydrogel can then be extracted from the 
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channel and placed in a variety of in vitro cell migration platforms or in nerve guide 
conduits for in vivo nerve regeneration. Use of methacrylated gelatin as the selected 
hydrogel material creates a highly-crosslinked hydrogel which provides prolonged release 
of NF and which is stable at physiological conditions [33].  
Gradient length scales are easily tailored by controlling the channel dimensions and 
further modified by changing the amount of time the gradients are established or by 
changing the inlet volume. By controlling the concentration of NF pre-loaded into the 
channel and NF in the droplet placed at the inlet, linear gradients of controllable 
concentration ranges and length scales can be established, as seen in Figure 2.2. The ability 
to use this method to generate well-controlled gradients at multi-centimeter scales allows 
for translation of gradient delivery for in vitro migration assays similar to those established 
using microfluidics-based platforms [7, 17, 18, 20, 29, 30], but with the scalability and 
ability to transfer the gradients into NGCs for in vivo gradient delivery, which is currently 
only feasible using gradient techniques for which gradient characteristics are less defined 
[16, 25, 26, 28].  
In addition to the multi-centimeter scale configuration originally developed by 
Khademhosseini et al., we modified the technique to decrease the length scale and increase 
the gradient generation throughput by fabricating parallel channel arrays (Figure 2.3) with 
which we could simultaneously produce numerous gradient hydrogels on smaller scales 
for easier incorporation in our in vitro cell migration platforms. By increasing the 
scalability of this method, we can simultaneously establish numerous gradient-loaded 
hydrogels for gradient delivery for high-throughput in vitro NF gradient screening and to 
ease production of gradient-loaded NGCs. The scalability of this method exhibits a 
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substantial advantage compared to microfluidics-based methods [7, 17, 18, 20, 29, 30], 
printing-based methods [10, 19], segmented gradients [16], or gradients generated using 
gradient mixers [9, 13] or electrospinning and extrusion methods [25, 26, 28], which 
generally require gradients to be produced one at a time. An additional benefit of this 
method is that it requires only small volumes of NF solution (<20 µL) to produce 
centimeter-scale gradients. By developing a low-volume gradient generation method, 
minimal NF is wasted during the gradient generation process and a significantly greater 
number of gradients can be produced from one NF stock compared to other gradient 
generation platforms. Printing-methods require small droplet volumes on the nanoliter 
scale, but it is unclear as to how many droplets are required to generate a centimeter-scale 
gradient [10, 19, 22] and the limited scalability and gradient stability reduce the potentially 
applicability of these methods. Gradient chambers [6, 8, 34] and gradient mixers [9, 13] 
are capable of generating controllable centimeter-scale gradients, but require significantly 
greater volumes of NF solution (100-1000 µL) to produce equivalent gradient 
characteristics. The high degree of gradient control at multi-centimeter length scales and 
ease of scalability make this gradient generation platform very unique in its capability for 
both short (<1 cm) and long (>1 cm) gradient generation for both in vitro and in vivo 
delivery that is difficult to achieve using other methods. 
2.3.2 Release of gradients from methacrylated gelatin hydrogel 
After loading of gradients into MG hydrogels, we needed to determine if NF 
gradients loaded into the MG hydrogels were released in a gradient-like fashion. We 
designed a release study investigating if GDNF was released in gradient hydrogels at rates 
that were proportional to the loading concentration within the different regions of the 
35 
 
hydrogel (i.e. differences between release rates in the high concentration regions versus the 
low concentration regions). Briefly, we established GDNF gradients in triplicate in MG 
hydrogels and cut the hydrogels into six equal-sized segments. Each segment was placed 
in separate wells of a 96-well plate and immersed in PBS. The PBS solution was collected 
and replaced on days 1, 3, 7, and 14, and GDNF release into the solutions collected was 
measured by use of an ELISA. From our release studies, we were able to see that release 
rates from the hydrogels differed in the 6 regions of the hydrogels, with higher release rates 
occurring in the highest concentration regions of the hydrogel and decreasing with 
decreasing GDNF loading (Figure 2.4). The greatest percentage of release was on day 1 
with gradient release continuing for at least 14 days. After the 14 days, the hydrogels 
largely remained intact and much of the initial GDNF loaded in the hydrogels remained 
sequestered within the hydrogels.  
Additionally, we tested whether incorporation of methacrylated heparin into the 
MG hydrogels during the GDNF loading phase altered the release rate of GDNF from the 
hydrogels. For this release study, methacrylated heparin was mixed with GDNF at 1:1 or 
10:1 ratios of heparin to GDNF and allowed to bind for 1 hour before pipetting the 
heparin/GDNF solutions onto the inlet of their respective gradient channels. Hydrogels 
were sectioned into six equal sized segments and the release study was conducted as before. 
Methacrylated heparin was used to conjugate the heparin to the MG hydrogel and act as an 
additional method to sequester GDNF to the hydrogel through heparin-GDNF binding. We 
initially hypothesized that the inclusion of heparin in the hydrogel formulation would 
reduce the release rate of GDNF from the MG hydrogel. Heparin-based controlled release 
systems have been used to prolong the release of NFs in nerve guides to enhance the 
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therapeutic efficacy of NF delivery [35-37]. However, from this study, we saw that the 
inclusion of heparin increased the rate of release from our hydrogels (Figure 2.5) compared 
to MG hydrogels without heparin. The release rate was actually highest for the highest 
concentration of methacrylated heparin. One possible explanation is that the inclusion of 
methacrylated heparin decreases the crosslinking density of the MG hydrogel by 
competitively conjugating to the methacrylate groups on the gelatin. Even though heparin 
itself is capable of binding to GDNF and slowing release, the data indicate that the potential 
decrease in crosslinking density offsets any benefits of heparin binding and causes a faster 
rate of release from the hydrogel. Due to these findings, future studies using MG hydrogels 
in in vitro and in vivo gradient delivery experiments did not include the use of 
methacrylated heparin in the formulations in order to provide more sustained release of NF 
from the hydrogels. 
2.3.3 Diffusion-based gradient generation platform characterization 
In addition to making modifications to the microfluidics-based convection-driven 
gradient method for in vitro cell migration studies, we developed a convection-free, 
tailorable, scalable gradient generation platform capable of creating NF gradients in the 
presence of cultured cells. Our gradient platform relies primarily on the diffusion of NFs 
in a microfabricated channel between a “source” and “sink” well (Figure 2.6). In this setup, 
the channel is filled with media, PBS, hydrogel, or cell solution in order to seed cells at the 
base of the channel prior to gradient establishment. If studying a non-zero baseline 
concentration of growth factor, the baseline level of growth factor can be loaded at this 
step, or can be loaded at the next step of the process. After pre-filling the channel, one of 
the wells is sealed with a removable PDMS stamp. The unsealed “sink” well is filled with 
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media or PBS containing no growth factor or containing the baseline concentration of the 
growth factor. After filling the “sink” well, it is sealed with a removable PDMS stamp and 
the stamp on the “source” well is removed. The “source” well is then filled with the highest 
desired concentration of growth factor and sealed with a PDMS stamp. Concentration 
differences between the “source” and “sink” wells result in a diffusion gradient being 
established between the two wells over the course of 4 – 24 hours depending on the 
molecular weight of the molecule of interest (Figure 2.7b). During this time, a well-
controlled linear gradient is established between the two wells, which can be easily 
modeled using COMSOL (Figure 2.7a). As seen in Figure 2.7, centimeter-scale gradients 
can be generated using this method, beyond the size limitations of most microfluidics-
based designs [7, 17, 18, 20, 29, 30] while still maintaining excellent control of gradient 
characteristics for prolonged periods of time (>24 hours).   
The use of the seal on the wells prevents gravity-driven flow from occurring in the 
channel after loading one of the wells, allowing the contents of each individual well to be 
replaced without disturbing the contents of the central channel or of the opposite well and 
keeping gradient generation convection-free. Convection-free gradient generation allows 
for the examination of the influence of gradients on shear-sensitive cell types, which would 
not be capable in flow-based systems [17, 32]. Neurons are known to be sensitive to shear 
and exhibit axonal retraction under excessive fluid shear conditions [17], for which 
convection-based gradient generation methods are not suitable. Figure 2.8 shows human 
Schwann cells cultured in gradient-generation channels prior at different time points after 
gradient generation was begun. Cells were seeded in the channels before beginning the 
gradient generation process. As can be seen, cells were viable after 4 hours of gradient 
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generation (Figure 2.8a) and remained viable 18 hours after gradient generation began 
(Figure 2.8b). Diffusion-based gradient generation does not rely on convection or flow to 
generate gradient profiles, and therefore does not exert fluid shear on cells during the 
gradient generation process and making this method compatible with neurons and Schwann 
cell cultures. Although gradient generation using this method is slower than for the 
convection-driven method, the ease of gradient generation using this method allows for 
fast and simple generation of a high number of simultaneous samples, increasing the 
scalability of gradient generation and allowing for the simultaneous testing of many 
gradient conditions. The scalability of this method provides a major advantage over 
methods for which gradient production must occur sequentially [7, 9, 10, 13, 16-20, 25, 26, 
28-30]. Our diffusion-based gradient method, like the convection-driven gradient method, 
requires only small volumes of NF solution (<20 µL) to produce centimeter-scale 
gradients, using significantly lower volumes of NF and minimizing NF waste compared to 
comparable methods [6, 8, 9, 13, 34]. The volumetric efficiency of this method is incredibly 
important when using expensive NFs or drug compounds. 
2.3.4 Use of diffusion-based gradient generation method for establishment of 
gradients in hydrogel films 
In addition to being able to form gradients directly in the channel using our novel 
diffusion-based gradient generation method, we are able to utilize this method to establish 
gradients within hydrogel films using a wide variety of hydrogel materials. Hydrogel films 
are first formed within PDMS frames of tailorable dimensions. First, a thin PDMS sheet is 
created by polymerizing Sylgard 184 monomer and crosslinker at 10:1 mass ratio between 
aluminum plates, using double-sided tape to control the spacing of the plates and allowing 
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for easy control of PDMS sheet thickness. PDMS frames are then cut to the desired 
dimensions from the sheet. Hydrogels can then be polymerized within the frames to 
produce thin frames of hydrogels with easily tailorable dimensions, and a wide variety of 
hydrogel materials can be used, including but not limited to collagen, methacrylated 
gelatin, fibrin, Matrigel, hyaluronic acid, and PEG-based materials. After the hydrogels are 
formed, gradient channels are placed over the PDMS frame and gradients are established 
using the method described in section 2.2.5. While the gradients form in the channel, the 
molecule of interest diffuses into the underlying hydrogel, simultaneously encapsulating 
the gradient in the hydrogel (Figure 2.9). Comparable gradient generation techniques 
which create hydrogel-based gradients suffer from the requirement for vastly higher 
volumes of NF (100-1000 µL per sample) [6, 8, 9, 13, 16, 34] compared to our diffusion-
based gradient method. Furthermore, this method has been adopted for functionalizing 
various other material platforms developed in our lab, including hydrogel-based 
electrospun fiber sheets (Figure 2.10), further demonstrating the extensive utility of this 
gradient generation technique. 
In collagen hydrogels, the gradient generation in the channel and in the hydrogel 
was characterized by establishing gradients of FITC-lysozyme and imaging the channel 
and hydrogel before and after removal of the channel using a Typhoon Gel Reader. After 
four hours of gradient establishment, it can be seen that the gradients in the channels 
(Figure 2.11a) were transferred to the collagen hydrogel (Figure 2.11b), forming a highly 
linear gradient in the hydrogel film. The hydrogel film can then be dried and transferred 
for use in in vitro or in vivo gradient delivery platforms, similar to the hydrogel created 
using the convection-based gradient generation method. Using this method, we have begun 
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investigating guidance of motor neurons in an in vitro spinal cord organotypic model to 
demonstrate the influence of GDNF gradients on directional motor neuron outgrowth 
(Figure 2.12). Additionally, this method can be modified to generate gradients in the 
presence of cells cultured on hydrogel films. Cells can be pre-seeded within or on top of 
the hydrogel films prior to gradient generation, and live-cell 2D and 3D cell migration 
studies can be conducted using this gradient generation platform, further increasing the 
utility of this method. The technique of separately sealing the wells allows for simple 
replacement of “source” and “sink” well contents and for use in long-term gradient studies. 
An example is shown in Figure 2.13 where dorsal root ganglion neurons were cultured on 
a Matrigel film in a 0-10 ng/mL NGF gradient for three days, with the contents of the 
“source” and “sink” wells being replenished daily. The DRGs demonstrated robust survival 
over the course of the 3 days and confirmed the viability of this platform for use in long-
term, multi-day gradient migration assays. 
 Conclusions 
We were able to establish two scalable gradient generation platforms which both 
demonstrate excellent control of gradient characteristics and are capable of generating 
centimeter-length gradients. The first method provides rapid, scalable, convection-based 
generation of multi-centimeter gradients encapsulated within a crosslinked methacrylated 
gelatin hydrogel for ease of in vitro and in vivo gradient delivery. By conjugation of 
methacrylated heparin, the release kinetics of the hydrogel can be tailored depending on 
the desired rate of release. The second method provides shear-free gradient generation, 
which demonstrates significant utility, capable of generating highly controlled, stable 
centimeter-length gradients in the presence of cells, can be used to establish gradients in 
41 
 
2D and 3D culture systems, and which is capable of long-term gradient culture. The 
combination of these two gradient techniques will provide significant insight into the 
influence of NF gradient delivery on neuron and Schwann cell guidance using in vitro live-
cell migration to analyze cell migration kinetics and translating the gradients into our NGCs 














Figure 2.1: Rapid, convection-based gradient generation method. (a) Microfluidics 
channel with tailorable channel dimensions, channel height of 100 µm. (b) Channel is 
pre-filled with photocrosslinkable methacrylated gelatin (MG), large volume of MG 
is pipetted onto outlet, and small volume of NF pipetted onto inlet. (c) Surface tension 
drives convection-based flow of NF droplet into channel and establishes gradient. (d) 








Figure 2.2: Generation of multi-centimeter scale gradients of FITC-lysozyme using 
convection-based gradient generation method with controllable gradient 









Figure 2.3: Gradient length can be tailored by modifying channel dimensions. (a) 
Gradient of FITC-lysozyme in 8 mm long channel. (b) Parallel channel configuration 






Figure 2.4: Gradient release from GDNF gradient-loaded hydrogel film (N = 3). 
Films were produced in triplicate and were sectioned into six pieces and release 
was measured using GDNF ELISA and compared to standards per ELISA 









Figure 2.5: Cumulative release of GDNF from methacrylated gelatin with different 
levels of methacrylated heparin loading (N=3). Release was measured using GDNF 








Figure 2.6: Diffusion-based gradient generation platform consisting of a 
microfluidics channel (10 mm length by 4 mm width by 100 µm height) 
with a 3 mm diameter “source” well and 3 mm diameter “sink” well. 
Channel is filled with media or PBS, and “source” and “sink” wells are 
filled with media/PBS or NF. Diffusion gradient establishes in channel 





Figure 2.7: Time-progression of diffusion-based gradients. (a) COMSOL 
modeling of diffusion-based gradient generation platform showing time-
course of gradient generation. (b) Experimental generation of FITC-
lysozyme gradient in diffusion-based gradient channels. Gradient was 






Figure 2.8: Human Schwann cell viability in diffusion-based gradient 
channel in 0-10 ng/mL NRG1 gradient. (a) Schwann cells were well-
adhered 4 hours after beginning gradient generation. (b) Schwann cells 





Figure 2.9: Modification of diffusion-based gradient generation platform 
for functionalization of hydrogel films. Hydrogel films (1 cm by 4 cm by 
500 µm) are polymerized in PDMS frames. Gradient channels are placed 
over the films and gradients are generated in the channel, transferring to 





Figure 2.10: FITC-Lysozyme gradient in fibrin hydrogel fiber sheet 
generated using diffusion-based gradient generation method. High 
concentration (100 µg/mL) of FITC-Lysozyme located on the right end of 






Figure 2.11: FITC-Lysozyme gradient generated in collagen hydrogel using 
diffusion-based gradient method. (a) Gradient in channel above hydrogel. (b) 
Gradient in collagen hydrogel after channel has been removed. Gradient was 






Figure 2.12: Directed motor neuron (red) migration in spinal cord 
organotypic culture on collagen hydrogel loaded with 0-1 ng/mL GDNF 











Figure 2.13: Dorsal root ganglion explants cultured on Matrigel, showing 
neuron survival and growth after 3 days in 0-10 ng/mL NGF gradient 
culture in modified diffusion gradient channels. Visualized using Nikon 
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Chapter 3 : Effect of Neurotrophic Factor Gradient Profile on 
Schwann Cell Migration in Culture 
 Introduction 
Neuron guidance by controlled NF delivery, as described in chapter 1 and chapter 
2, has been extensively investigated. However, little effort has been made in the guidance 
of Schwann cells, particularly through the use of topographical and biochemical gradients, 
to direct endogenous Schwann cell migration into the site of nerve injury to enhance the 
efficacy of regeneration. The presence and activity of Schwann cells is of great importance 
in enhancing nerve regeneration due to the numerous roles of Schwann cells in the nerve 
repair process, during which Schwann cells precede the axons into the lesion site secreting 
extracellular matrix tracks called bands of Büengner upon which regenerating axons grow 
[1-4]. It has been shown that Schwann cells, especially in the distal stump of the nerve 
injury, produce a cocktail of NFs to promote neuron survival and growth of regenerating 
neurons into the distal stump [1, 2]. Seggio et. al. demonstrated the capability for aligned 
Schwann cell monolayers to guide DRG neuron outgrowth in in vitro culture, illustrating 
the inherent proficiency of Schwann cells in directing axonal extension and regeneration 
[5].  By harnessing this natural capability of endogenous Schwann cells and increasing the 
rate of Schwann cell infiltration into a nerve injury gap, regeneration of the injured nerve 
may be enhanced by utilizing the mechanisms inherent in axon-glial interactions. 
One potential method for guiding Schwann cell migration utilizes aligned 
topographical cues to constrain Schwann cell migration along a single axis. Daud et. al. 
compared the effects of 1, 5, and 8 µm diameter fibers on the migration of Schwann cells, 
neurons, and neuron-glia co-cultures [6]. It was shown that Schwann cells migrated the 
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furthest distance on 1 µm diameter fibers, significantly different than result for neurons 
which extended fastest on 8 µm diameter fibers. In co-cultures, Schwann cells formed a 
migration front upon with axons trailing behind, migrating preferentially on the Schwann 
cell basal lamina instead of the underlying fibers. One main limitation of the study was that 
they did not investigate cell migration on sub-micron diameter fibers to determine if there 
exists an optimal diameter range for promoting maximal Schwann cell migration rate and 
migration guidance. However, the study provided substantial evidence that neuronal 
outgrowth is largely dependent on Schwann cell migration and basal lamina production, 
and further strengthens the hypothesis that increasing Schwann cell migration into a nerve 
injury can enhance the regrowth of neurons into the injury site. 
Schwann cell migration can also be influenced by the presence of exogenous NF. 
Paratcha et al. have previously shown GDNF to be a potent migratory stimulant for 
Schwann cells via co-association with GDNF receptor alpha-1 (GFRα1) and neural cell 
adhesion molecule (NCAM) [7].  While it has previously been shown that NGF 
conditioning of Schwann cells increases their motility [8], studies by Cornejo et al. using 
Schwann cell precursor cells showed limited chemotropic activity of NGF compared to 
GDNF and to a lesser degree, NRG-1 [9]. Certain soluble of isotypes of NRG-1 are capable 
of increasing Schwann cell motility [10], but Cornejo et al. demonstrated that NRG-1 
exhibits only modest chemotropic activity in Schwann cell precursors compared to GDNF 
and macrophage inhibitory factor, a known potent chemotropic agent for Schwann cells 
[9]. Additionally, NRG-1 has been shown to influence Schwann cell proliferation, 
especially at higher concentrations [11], which may limit its role as a chemoattractant in in 
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vivo NGCs where higher NF concentrations may be necessary to provide prolonged 
delivery of therapeutic concentrations of NFs. 
In Chapter 3, we develop a novel migration chamber which combines topographical 
and biochemical gradient guidance with a live-cell imaging and analysis program to 
investigate the migratory response of human Schwann cells to different topographical and 
biochemical cues. We utilize the migration chamber to track and analyze the migration of 
thousands of cells simultaneously and compare the influence of fiber diameter, NF type, 
and NF gradient characteristics on the directed migration of Schwann cells. Here we report 
Schwann cell migration on a wide range of aligned electrospun fiber diameters ranging 
from 180 nm to 2 µm to determine the optimal fiber diameter for use in subsequent in vitro 
cell migration models as well as for incorporation into NGCs which combine aligned 
nanofibers on the surface of the lumen as well as hydrogel-based NF gradient delivery. The 
migration platform is used to determine the efficacy of multiple NF and gradient conditions 
on Schwann cell guidance, eliciting the effects of NF type, gradient concentration range, 
and gradient steepness in the directional guidance of Schwann cells. Using this method, we 
gained tremendous insight into which topographical and NF gradient parameters promote 
optimal guidance of Schwann cells, which can be used to improve the design and function 
of NGCs capable of enhancing Schwann cell and neuron growth. This work also highlights 
the potential for utilizing this platform for the study of cell and tissue engineering fields 




3.2.1 Aligned nanofiber sheet preparation 
Nanofiber sheets were generated using an electrospinning setup commonly utilized 
in our lab (Figure 3.1). In brief, polycaprolactone (PCL)-solvent solution is added to a 1-
mL plastic syringe. A blunt-end 27-gauge needle is added to the syringe and the syringe is 
placed in a syringe pump (KD Scientific, Holliston, MA). The syringe pump is mounted 
on a linear stage (Newmark Systems, Rancho Santa Margarita, CA) to allow controllable 
deposition of polymer solution over the area of interest. The needle is connected to a DC 
power supply (Gamma High Voltage power supply, Ormond Beach FL) to generate a 
positive charge to the solution at the tip of the of the syringe needle. A rotating collection 
wheel (40 cm diameter) is placed at a controlled distance from the end of the needle and is 
attached an electrical ground. Rotation of the collection wheel is controlled by a Dayton 
DC Speed Control. Aligned fiber sheets are created on the surface of the rotating wheel by 
extruding PCL solution through the end of the needle and applying a charge to the solution, 
resulting in deposition of fibers on the rotating wheel surface. After deposition onto the 
wheel surface, fiber sheets are removed from the wheel and cut to the desired size for in 
vitro migration studies. Fiber diameter can be tailored by controlling the PCL-solvent 
composition, collection distance, and wheel rotation speed. With this method, fiber sheets 
can be manufactured with fiber diameters ranging from 180 nm to 8 µm.  
3.2.2 Aligned fiber coverslip preparation for fiber diameter screening 
Nanofiber coverslips were prepared by modification of the method described in 
section 3.2.1. Coverslips were taped to the spinning wheel and fibers were deposited on 
the surface of the coverslips. Fibers were immobilized to the surface of the coverslips by 
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pipetting Factor 2 silicone surgical glue onto the outer edges of the coverslips. After fiber 
immobilization, coverslips were sterilized via either 40 min exposure to UV in the 
biosafety hood or ethylene oxide sterilization. The coverslips were glued to the bottom of 
the 24-well plates with Factor 2 silicone surgical glue, which was allowed to vent overnight 
to remove residual solvent. The coverslips were then washed with PBS and coated for cell 
adhesion by soaking in 1/100 Matrigel solution overnight at 37°C. The coverslips were 
washed the following day with PBS and were equilibrated for 1 hour at 37°C with the cell 
media prior to adding the spheroids or single cells for live cell tracking. 
3.2.3 Live-cell tracking of human Schwann cells on aligned nanofibers 
Fetal-derived primary human Schwann cells were purchased from Sciencell 
(Carlsbad, CA). The Schwann cells were seeded for two days prior to experiment and 
exposed to 1 µg/mL Hoechst 33342 (Pierce) for 30 minutes prior to use. Cells were washed 
to remove unused Hoechst, trypsinized, resuspended in cell solution, and pipetted at a 
concentration of 1000 cells per well onto each coverslip and allowed to adhere for 6 hours 
prior to cell tracking. Cell migration was observed every 10 minutes for 12 hours using a 
live cell imaging microscope with programmable stage (Nikon) and environmental 
chamber (37°C, 5% CO2, and 100%RH). Cell migration was analyzed using a custom cell 
tracking and analysis software package developed by our lab. 
3.2.4 Combinatorial biochemical gradient and topographical guidance cell tracking 
platform 
For NF gradient comparison experiments, hydrogels (1 cm in length) containing 
NF gradients of GDNF (0 to 1 µg/mL and 0 to 10 µg/mL), NGF (0 to 1 µg/mL and 0 to 10 
µg/mL), and NRG-1 (0 to 1 µg/mL and 0 to 10 µg/mL) were prepared and placed on 15 
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mm coverslips. For GDNF steepness comparison experiments, hydrogels (1 cm in length) 
containing GDNF gradients (0 to 1 µg/mL/cm, 0 to 10 µg/mL/cm, or 0 to 20 µg/mL/cm) 
were prepared and placed on 15 mm coverslips. Aligned electrospun fibers were placed 
over the hydrogels and immobilized using factor 2 tissue glue. A custom PDMS migration 
channel (4 mm by 10 mm by 0.1 mm) was placed over the hydrogel/fiber construct. 
Primary human Schwann cells (ScienCell) were seeded for two days prior to experiment 
and exposed to 1 µg/mL Hoechst 33342 (Pierce) for 30 minutes prior to use, washed with 
PBS, trypsinized, injected into the channel at 1000 cells per sample and allowed to adhere 
for 6 hours prior to cell tracking. Cell migration was observed using live cell imaging 
microscope with programmable stage (Nikon) and migration was analyzed using a custom 
cell tracking and analysis software package developed by our lab.  
3.2.5 Cell tracking and analysis programming 
Automated tracking of the cell images was done using the Trackmate plugin within 
the Fiji image processing program (Trackmate developed by Nick Perry, Jean-Yves 
Tinevez, Johannes Schindelin). Cells were identified by a Gaussian filter blob detection 
algorithm, and individual tracks were subsequently stitched together using a Linear 
Assignment Problem algorithm. Parameters for both detection and stitching algorithms 
were adjusted to optimize cell path quality on a file-by-file basis. Cell path attributes were 
calculated with a Matlab and Python-based routine developed in our lab using the 
spatiotemporal data outputted by Trackmate. Correlations of path attributes to local 
spatiotemporal areas were made by calculating weighted averages of attributes; the weights 
being the range of frames across which paths exist. Directionality for each cell is calculated 
as follows: 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 =
∑ 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑣𝑣𝐶𝐶𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣 ∙ 𝐹𝐹𝐹𝐹𝐶𝐶𝐶𝐶𝐹𝐹 𝑣𝑣𝐶𝐶𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣
𝑛𝑛𝑣𝑣𝑣𝑣𝑛𝑛(𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑣𝑣𝐶𝐶𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣) × 𝑛𝑛𝑣𝑣𝑣𝑣𝑛𝑛(𝐹𝐹𝐹𝐹𝐶𝐶𝐶𝐶𝐹𝐹 𝑣𝑣𝐶𝐶𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣)
𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁 𝑜𝑜𝑜𝑜 𝑜𝑜𝑁𝑁𝑓𝑓𝑁𝑁𝑁𝑁𝑓𝑓
, where “Cell vector” is the 
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positional vector a cell has moved in one frame and “Field vector” is the vector defined as 
the direction of the gradient. Error bars show average ± Standard Error. Migration speeds 
are represented as average ± Standard Error. 
 Results and Discussion 
3.3.1 Effect of aligned fiber diameter on Schwann cell migration 
Using a live-cell imaging platform allows us to monitor the migration of large 
populations of Schwann cells, at a single-cell level, to elucidate the influence of local 
environmental factors, such as surface topography and the presence of biochemical cues. 
We first began investigating the effects of aligned fiber diameter on Schwann cell motility, 
utilizing electrospinning techniques developed in our lab to compare a wide variety of fiber 
diameters, ranging from 180 nm to 2 µm. In order to image Schwann cells through optically 
opaque aligned fibers, the Schwann cells first had to be labeled with a nuclear stain, 
allowing for simple tracking of individual cells by increasing the signal contrast between 
the cells and the underlying fibers (Figure 3.2). By seeding labeled cells on coverslips 
coated in aligned fibers of different diameters and using our cell tracking and analysis 
platform to track cell migration over the course of 12 hours, we were able to determine that 
Schwann cell migration was most optimal on 1.2-µm diameter fibers (Figure 3.3a). 
Schwann cell migration speed was substantially higher on the 1.2-µm diameter fibers 
(37.9 ± 0.68 µm/h) compared to smaller (25.8 ± 0.80 µm/h) and larger diameter 
(26.9 ± 0.74 µm/h) fibers (Figure 3.3b). This result was similar to the finding by Daud et 
al. who found Schwann cell migration was greatest at a diameter of 1 µm [6], but they did 
not compare fiber diameters below 1 µm. Further analysis of the fiber setup used by Daud 
et. al. showed lower density of fibers than those used in our study. Whereas the Schwann 
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cells were largely restricted to single fibers in the Daud setup, Schwann cells in our 
migration platform showed preferential migration between multiple fibers regardless of 
fiber diameter. This disparity results in significant differences in maximum Schwann cell 
migration rate in our high density 1.2 µm fibers (37.9 ± 0.68 µm/h) compared to that of the 
low density 1 µm fibers (11.25 µm/h) [6] in the setup by Daud et. al. Increasing the density 
of aligned fibers to allow attachment of Schwann cells to multiple adjacent fibers appears 
to result in increased migration rate compared to Schwann cells restricted to single fibers. 
This indicates that NGCs designed to increase Schwann cell infiltration should be designed 
with high aligned fiber densities in order to maximize the motility of Schwann cells 
migrating on the aligned fiber substrate. 
Our results also demonstrate the existence of an optimal fiber diameter range for 
Schwann cell guidance in high-density fiber substrates. On fibers with an average diameter 
of below 1 µm, Schwann cell migration was slowed due to the ability for Schwann cells to 
transmigrate across multiple fibers and was not restricted to the migration axis dictated by 
the fiber alignment. Fibers with an average diameter of 1 µm and above successfully 
restricted cell migration along the fiber axis, but Schwann cell migration rate slowed on 
larger diameter fibers. Schwann cells tended to migrate fastest when migrating between 
parallel fibers, which was mostly possible for fibers with an average diameter of 1 µm and 
smaller. For larger diameter fibers, the Schwann cells were restricted to single-fiber 
migration, potentially resulting in slower migration rate. While we currently lack the 
mechanistic understanding behind these phenomena, the results gleaned from this 
experiment were useful in the design of studies incorporating aligned nanofibers into 
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biochemical gradient models and in the selection of fiber diameter for our aligned fiber 
NGCs. 
3.3.2 Effect of NF type on Schwann cell migration 
In order to investigate the influence of different types of NF types and gradient 
concentrations in Schwann cell guidance, we developed a novel migration chamber, which 
combined topographical guidance from aligned nanofibers with NF gradients delivered 
from methacrylated gelatin hydrogels (Figure 3.5). Gradients were generated in 1-cm long 
methacrylated gelatin hydrogels using the methods described in Chapter 2. The growth 
factors selected for comparison were glial-derived neurotrophic factor (GDNF), nerve 
growth factor (NGF), and neuregulin-1 (NRG-1), and 1 cm length gradients were generated 
for each NF with two concentration ranges, 0 – 1 µg/mL and 0 – 10 µg/mL. Human 
Schwann cells were seeded within the migration chambers and incubated for 6 hours before 
observing cell migration for an additional 12 hours using a live-cell imaging microscope. 
The presence of aligned fibers in the migration chamber played an important role in the 
restriction of cell migration along a single axis, which simplified cell tracking and analysis 
and to better attribute any directional bias to the specific gradient conditions imposed on 
the cells. 
After cell tracking and analysis, we were able to demonstrate that GDNF was the 
most potent NF in promoting directional Schwann cell migration (Figure 3.6) within the 
concentration ranges tested, with both the 0 – 1 µg/mL and 0 – 10 µg/mL gradients 
successfully promoting biased migration of the Schwann cells. The strong migrational bias 
elicited by GDNF gradients supplements the results from Paratcha et al. who have 
previously shown GDNF to be a potent migratory stimulant for Schwann cells [7].  NGF 
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and NRG-1 did not elicit a strong directional migratory response in human Schwann cells. 
Cornejo et al. showed limited chemotropism of Schwann cell precursors in response to 
NGF gradients [9], although there may exist a concentration-dependent effect on Schwann 
cell motility [8]. The limited directional guidance elicited by NRG-1 was also similar to 
the results by Cornejo et al., who saw modest chemotropic activity in Schwann cell 
precursors in NRG-1 gradients with a maximum gradient concentration of 200 ng/mL (2 
µg/mL/cm steepness) compared to GDNF gradients with equivalent concentration range 
[9]. While the chemoattractant effects of these NFs may differ depending on the Schwann 
cell maturity [9], these data suggest that GDNF is a suitable candidate for the study of 
gradient-based chemotropic guidance of Schwann cells. With its capability as both a potent 
Schwann cell chemoattractant and survival cue for motor neurons [12], much of our 
subsequent in vitro and in vivo research focused on the delivery of GDNF gradients and 
the influence of GDNF gradient characteristics on its tropic activity.  However, it should 
be noted that chemotropic efficacy may vary significantly depending on the concentration 
range of the gradients presented [13-18], and different NFs may have different therapeutic 
concentration ranges. Future studies will need to consider these differences and investigate 
larger gradient concentration ranges in order to further optimize gradient migration 
guidance of Schwann cells. 
3.3.3 Effects of GDNF gradient characteristics on chemoattractive activity 
Given our findings demonstrating the efficiency of GDNF as a chemoattractant 
when delivered via gradient-loaded hydrogels, we utilized the combinatorial topographical 
and biochemical guidance migration chamber platform to investigate the effect of GDNF 
gradient steepness and concentration range on the guidance of Schwann cells. We 
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compared three gradient conditions of differing steepness configurations and concentration 
ranges, and evaluated the effect of different gradient characteristics on the migration 
guidance of human Schwann cells. One gradient condition ranged from 0 to 1 µg/mL 
maximum concentration with 1 cm total length (1 µg/mL/cm gradient steepness)  while 
two gradient conditions (10 µg/mL/cm and 20 µg/mL/cm) used the same maximum 
concentration (10 µg/mL) of GDNF but differed in gradient length (1 cm for the 10 
µg/mL/cm condition, 0.5 cm for the 20 µg/mL/cm condition) allowing us to directly 
compare both the influence of gradient steepness as well as concentration range. Gradient 
concentrations were selected based on previous work by Cao et. al. who demonstrated 
dose-dependent PC12 migration in concentration ranges of 0.1 µg/mL to 1 µg/mL NGF 
[14] and Moore et. al. who demonstrated directional guidance in chick DRG neurons in 
gradients of maximum concentrations up to 50 µg/mL [17], and gradient steepness was 
based on Cornejo et. al. which used 2 µg/mL/cm steepness GDNF gradients for Schwann 
cell precursor guidance [9]. Taking into account potential differences between the 
therapeutic window of GDNF and differences between neuronal and Schwann cell 
guidance, we used intermediate GDNF concentrations between the ranges of those used 
for NGF and gradient steepness values comparable to those used to guide Schwann cell 
precursors. 
 Using our live-cell imaging and analysis platform, we evaluated the migration of 
thousands of Schwann cells migrating under different gradient conditions and analyzed 
their migration characteristics in response to the imposed gradients. Figure 3.7a-c show 
positional heat maps of the migration bias of each individual Schwann cell under different 
gradient conditions. Every dot on the heat map corresponds to the weighted average 
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directional bias of an individual Schwann cell and is placed at the exact point of origin 
from which each cell was tracked. In these maps, red corresponds to cells which migrate 
positively towards the high concentration of the gradient, and blue corresponds to cells 
which migrate against the concentration gradient. In comparing the three gradient 
conditions, the shallowest GDNF gradient (1 µg/mL/cm steepness) exhibited the greatest 
level of directional bias of all gradient conditions, promoting a peak directional bias of 
63% positive cell migration near the high concentration region of the gradient (Figure 
3.7d). Peak directional bias decreased as gradient steepness increased, with a peak 
directional bias of 47% for the 10 µg/mL/cm gradient condition and 41% for the 20 
µg/mL/cm gradient condition. Within the 1 µg/mL/cm gradient condition, Schwann cell 
directional bias increased from 17% positive cell migration in the low concentration region 
of the gradient to the 63% positive cell migration in the highest concentration region of the 
gradient (Figure 3.7d), indicating a concentration range-dependent chemotactic response. 
In fact, this phenomenon was conserved within all gradient conditions (Figure 3.7d-f) 
regardless of maximum GDNF concentration or gradient steepness. Additionally, Schwann 
cell migration exhibited steepness-dependent migration in response to the different GDNF 
gradient conditions. This was most apparent in gradient regions containing GDNF 
concentrations near 1 µg/mL (1 µg/mL/cm – Region 6; 10 µg/mL/cm – Region 1) (Table 
3.1), where positive directional bias decreased with increasing steepness with 60% positive 
Schwann cell migration in the 1 µg/mL/cm steepness gradient condition, and 31% positive 
Schwann cell migration in the 10 µg/mL/cm steepness gradient condition. These data 
suggest Schwann cell guidance is strongly dependent on both the gradient concentration 
range as well as the gradient steepness. This result is consistent with research conducted 
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by Mortimer et al. demonstrating that concentration range and gradient steepness are both 
important determinants in the chemotropic effect of a NF gradient [18]. Interestingly, in 
the gradients with a maximum GDNF gradient concentration of 10 µg/mL, similar levels 
of positive directional guidance (>30% positive migration) were seen in gradient regions 3 
– 6 (Table 3.1, Figure 3.7e,f), but differed substantially in the lowest concentration regions 
(regions 1&2) where the shallower gradient exhibited greater positive Schwann cell bias. 
These results indicate that effective GDNF concentration range may differ depending on 
the steepness of the gradient. 
Further analysis of the migration shows that the gradient conditions significantly 
influence the distribution of Schwann cell migration bias (Figure 3.8). The distribution of 
the shallow GDNF gradient (Figure 3.8a) shows a relatively higher proportion of Schwann 
cells with a positive directional bias compared to cells in the higher concentration gradients 
(Figure 3.8b,c). However, there are also a higher proportion of Schwann cells that migrate 
against the gradient (Figures 3.7 and 3.8). When Schwann cells migrate on aligned fibers, 
they are able to migrate in two directions along the axis of the fibers. Some cells migrate 
in a single direction while others frequently switch direction of migration. In an 
environment where Schwann cells are exposed to a GDNF gradient, some cells oscillate 
(neutral) instead of migrating up the gradient (positive bias). However, there still exists a 
population of cells which began migrating against the gradient and maintain their path, thus 
appearing to migrate towards the low concentration (negative bias) unaffected by the 
gradient. Figure 3.8 shows the population distribution of migration directionality in 
Schwann cells in the three gradient steepness conditions. The distributions demonstrate 
that the lowest steepness gradient condition provides the strongest positive directional bias 
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(43% of total cell population), but cannot prevent a subpopulation of cells (15% of total 
cell population) from continuing to migrate against the gradient. Schwann cells in the 
highest steepness gradient, while less likely to migrate against the gradient (7% of total cell 
population), demonstrate a high tendency (62% of total cell population) to remain in a 
neutral, oscillatory state, and lower tendency to exhibit positive cell migration (30% of 
total cell population). The steepest concentration gradient thus exhibits the narrowest 
distribution of Schwann cell migrational bias with a majority of the cells existing in a 
neutral migratory state (Figure 3.8d). 
Additionally, both the steepness and concentration range influenced the migration 
rate of Schwann cells within the different gradient ranges. Cell migration rate was the 
highest for the 10 µg/mL per cm gradient group (12.0 ± 0.11 µm/h), but decreased as 
gradient steepness increased (7.6 ± 0.24 µm/hr) (Figure 3.9). This result indicates that 
while Schwann cell migration rate can be increased by increasing GDNF gradient 
concentration, gradient steepness must be tailored to prevent the “candy store” effect, in 
which cells are unable to detect the existence of a gradient and the NF conditions are 
favorable preventing Schwann cell migration out of the gradient region [19].  
The existence of optimal effective NF concentration range have been demonstrated 
in PC12 neurons [13, 15] and DRG neurons [14, 17, 18], but this is the first study, to our 
knowledge, that elucidates how NF gradient steepness and concentration range effect 
Schwann cell migration. While we gained tremendous insight into the use of NF gradients 
as a tool for guiding Schwann cell migration, further studies will be necessary to determine 
the optimal gradient conditions for maximizing directed Schwann cell migration. Current 
studies are ongoing which expand the cell tracking and analysis capability to the study of 
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neuron gradient guidance within our combinatorial platform. Although our migration 
channel platform is capable of providing significant insight into the influence of NF 
gradient delivery on single cell populations, it is important to consider how Schwann cells 
and neurons migrate under gradient conditions when in co-culture, which most closely 
mimics the conditions in an in vivo nerve injury. Further studies will be required to 
elucidate if axon-glial interactions modulate the response of Schwann cells and neurons to 
NF gradients by changing NF receptor expression via paracrine or juxtacrine signaling 
between neurons and glia. However, by creating a powerful gradient generation and 
migration analysis tool, we will be able to answer some of these questions in the near future 
and utilize the capabilities of our gradient generation and electrospun fiber platforms to 
develop the next generation of synthetic NGCs.  
 Conclusions 
We successfully developed a novel combinatorial migration chamber platform with 
which we could investigate the effect of topographical and biochemical gradient guidance 
on the migration kinetics of human Schwann cells. Utilizing live-cell imaging microscopy, 
we tracked and analyzed the migration of thousands of individual Schwann cells in 
response to topographical and biochemical cues. We found that Schwann cell migration 
was the fastest on aligned nanofibers of a diameter of 1.2 µm, a fiber size that was selected 
for use in future in vitro and in vivo models. By incorporating gradient delivery into the 
migration platform, we determined GDNF to be the most potent chemoattractive NF for 
human Schwann cells, and demonstrated the importance of gradient steepness and 
concentration on the directional bias and migration rate of Schwann cells. This platform 
provides insight into important design parameters for creating NGCs containing NF 
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gradient delivery and nanofiber topographical guidance for improving the efficacy of in 
vivo nerve regeneration. Our platform is a powerful tool for investigating biochemical and 





 Figures and Tables 
  
Maximum GDNF Concentration (µg/mL) 
Gradient Region Gradient Steepness 1 µg/mL/cm 10 µg/mL/cm 20 µg/mL/cm 
1 0.17 1.67 1.67 
2 0.33 3.33 3.33 
3 0.50 5.00 5.00 
4 0.67 6.67 6.67 
5 0.83 8.33 8.33 
6 1.00 10.00 10.00 
Table 3.1: Maximum GDNF concentration in different gradient regions based on 








Figure 3.1: Schematic of electrospinning setup used to generate aligned nanofiber 
substrates. A voltage is applied to an extruded polymer solution, which is deposited 
onto an electrically-grounded spinning metal wheel, resulting in the formation of 





Figure 3.2: Human Schwann cells visualized 
on aligned nanofibers with fluorescence 
microscope. Cells are stained with Hoechst 






Figure 3.3: Average migration rate of human Schwann cells on aligned fiber sheets 
with different fiber diameters (N > 1500 cells). (a) Migration speed distribution of 
cells in different regions of fiber sheets. (b) Weighted average migration speed of 





Figure 3.4: Population distribution of human Schwann cell migration speed on 





Figure 3.5: Schematic for production of combinatorial migration 
chambers incorporating aligned fiber topographical guidance and 






Figure 3.6: Human Schwann cell migration bias in response to gradients of 





Figure 3.7: Directional guidance of human Schwann cell migration to 
GDNF gradients (N>1000 cells). (a) Directional bias heat map of Schwann 
cells in 1 µg/mL/cm GDNF gradient. Dots represent position of cells in 
gradient. Red dots represent cells exhibiting positive directional bias. Blue 
dots represent cells exhibiting negative directional bias. (b) Directional bias 
heat map of Schwann cells in 10 µg/mL/cm GDNF gradient. (c) Directional 
bias heat map of Schwann cells in 20 µg/mL/cm GDNF gradient. (d) Percent 
of negative, neutral, or positive migrating cells in different regions of 1 
µg/mL/cm GDNF gradient. (e) Percent of negative, neutral, or positive 
migrating cells in different regions of 10 µg/mL/cm GDNF gradient. (f) 
Percent of negative, neutral, or positive migrating cells in different regions 





Figure 3.8: Population distribution of directional guidance of human 
Schwann cell migration to GDNF gradients (N>1000 cells). (a) Directional 
bias distribution of Schwann cells in 1 µg/mL/cm GDNF gradient in 
different hour ranges. (b) Directional bias distribution of Schwann cells in 
10 µg/mL/cm GDNF gradient in different hour ranges. (c) Directional bias 
distribution of Schwann cells in 20 µg/mL/cm GDNF gradient in different 
hour ranges. (d) Percent of negative, neutral, or positive migrating cells in 





Figure 3.9: Migration rate of human Schwann cells in GDNF gradients 
(N>1000 cells). (a) Migration rate heat map of Schwann cells in 1 µg/mL/cm 
GDNF gradient. Dots represent position of cells in gradient. Red dots 
represent cells migrating at average rate of 20 µm/h. Blue dots represent non-
migratory cells. (b) Migration rate heat map of Schwann cells in 10 
µg/mL/cm GDNF gradient. (c) Migration rate heat map of Schwann cells in 
20 µg/mL/cm GDNF gradient. (d) Average migration rate of total cell 





1. Bunge, R.P., Expanding roles for the Schwann cell: ensheathment, myelination, 
trophism and regeneration. Current Opinion in Neurobiology, 1993. 3: p. 805-809. 
2. Fu, S.Y. and T. Gordon, The cellular and molecular basis of peripheral nerve 
regeneration. Molecular Neurobiology, 1997. 14: p. 67-116. 
3. Ide, C., et al., Schwann cell basal lamina and nerve regeneration. Brain Research, 
1983. 288: p. 61-75. 
4. Fawcett, J.W. and R.J. Keynes, Peripheral nerve regeneration. Annual Review of 
Neuroscience, 1990. 13: p. 43-60. 
5. Seggio, A.M., et al., Self-aligned Schwann cell monolayers demonstrate an 
inherent ability to direct neurite outgrowth. Journal of Neural Engineering, 2010. 
7(4): p. 046001. 
6. Daud, M.F., et al., An aligned 3D neuronal-glial co-culture model for peripheral 
nerve studies. Biomaterials, 2012. 33(25): p. 5901-13. 
7. Paratcha, G., F. Ledda, and C.F. Ibáñez, The Neural Cell Adhesion Molecule NCAM 
Is an Alternative Signaling Receptor for GDNF Family Ligands. Cell, 2003. 113(7): 
p. 867-879. 
8. Anton, E.S., et al., Nerve growth factor and its low-affinity receptor promote 
Schwann cell migration. PNAS, 1994. 91(7): p. 2795-2799. 
9. Cornejo, M., et al., Effect of NRG1, GDNF, EGF and NGF in the migration of a 
Schwann cell precursor line. Neurochemical Research, 2010. 35(10): p. 1643-51. 
87 
 
10. Mahanthappa, N.K., E.S. Anton, and W.D. Matthew, Glial growth factor 2, a 
soluble neuregulin, directly increases Schwann cell motility and indirectly 
promotes neurite outgrowth. Journal of Neuroscience, 1996. 16(15): p. 4673-4683. 
11. Heermann, S. and M.H. Schwab, Molecular control of Schwann cell migration 
along peripheral axons. Cell Adhesion & Migration, 2013. 7(1): p. 18-22. 
12. Chew, S.Y., et al., Aligned Protein-Polymer Composite Fibers Enhance Nerve 
Regeneration: A Potential Tissue-Engineering Platform. Advanced Functional 
Materials, 2007. 17(8): p. 1288-1296. 
13. Cao, X. and M.S. Shoichet, Defining the concentration gradient of nerve growth 
factor for guided neurite outgrowth. Journal of Neuroscience, 2001. 103(3): p. 831-
840. 
14. Cao, X. and M.S. Shoichet, Investigating the synergistic effect of combined 
neurotrophic factor concentration gradients to guide axonal growth. Journal of 
Neuroscience, 2003. 122: p. 381-389. 
15. Kapur, T.A. and M.S. Shoichet, Immobilized concentration gradients of nerve 
growth factor guide neurite outgrowth. Journal of Biomedical Materials Research 
Part A, 2003. 68A(2): p. 235-243. 
16. Belkas, J.S., M.S. Shoichet, and R. Midha, Peripheral nerve regeneration through 
guidance tubes. Journal of Neurological Research, 2004. 26: p. 151-160. 
17. Moore, K., M. Macsween, and M.S. Shoichet, Immobilized concentration gradients 
of neurotrophic factors guide neurite outgrowth of primary neurons in 
macroporous scaffolds. Tissue Engineering, 2006. 12(2): p. 267-278. 
88 
 
18. Mortimer, D., et al., A Bayesian Model predicts the response of axons to molecular 
gradients. PNAS, 2009. 106(25): p. 10296-10301. 
19. Eggers, R., et al., Lentiviral vector-mediated gradients of GDNF in the injured 
peripheral nerve: effects on nerve coil formation, Schwann cell maturation and 




Chapter 4 : Effect of GDNF Gradient Delivery on Peripheral 
Nerve Regeneration in Rat and Canine Models 
 Introduction 
Current approaches to nerve regeneration have taken multiple platforms, ranging 
from biomaterials engineering to cell-based therapies, all attempting to match the current 
clinical gold standard, the autologous nerve graft. Inherent issues with both the harvest and 
utilization of the autologous nerve graft have generated momentum to develop effective 
nerve guidance conduits (NGCs) to repair the damaged nerve. The biomaterials approach 
to NGC design focuses on providing a microenvironment conducive for nerve regeneration 
by mimicking the extracellular matrix (ECM) present in regenerating nerves, employing 
substrate-bound and diffusible signaling cues to promote cell adhesion and survival and to 
guide axonal re-growth through the lesion site. Neurotrophic factors (NFs) that promote 
the survival and regenerative activities of nerves, and adhesive cues, such as laminin, are 
commonly incorporated into NGCs to enhance the regenerative outcomes [1-4]. The cell-
based approach to NGC design utilizes Schwann cells, often with potentiated functionality 
through the over-expression of NFs and the organization of an aligned structure similar to 
Bands of Büngner, to provide trophic support for axonal regeneration, to secrete relevant 
ECM and to myelinate regenerating axons. Alternative cell sources such as mesenchymal 
stem cells (MSCs) [5] and bone-marrow-derived stromal cells (BMSCs) [6-8] transplanted 
in NGCs have also been shown to be an effective approach to promoting axonal 
regeneration.  
Delivery of extrinsic signaling cues at the repair site has been shown to significantly 
improve the axonal survival and re-growth and thus the functional recovery. Particularly, 
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the ‘local’ administration of NFs within NGCs or autographs has demonstrated great nerve 
regeneration potential, prompting more effort in optimizing systems to regulate the local 
release of these cues and understanding how to most effectively present these cues to 
regenerating nerves [1-4, 9, 10]. One of the major challenges in effectively utilizing NFs 
is how to properly deliver them to the damaged nerve site to provide both localized and 
sustained release in order to maximize their efficiency. Sustained NF release can be 
provided by encapsulating them within crosslinked hydrogels [11, 12], microparticles [13], 
or micro/nanofibers [4]. The incorporation of NF-binding molecules or direct conjugation 
of NFs to the NGC substrate using a cleavable chemical linkage can also provide sustained 
release and enhanced regenerative capabilities [14, 15]. A recent study by Marquardt et al., 
which injected genetically-modified Schwann cells transfected with a tetracycline-
inducible GDNF-overexpressing lentivirus into the distal stump of a 3-cm sciatic nerve 
defect and showed the greatest regenerative outcome for the groups in which GDNF was 
overexpressed for 6 weeks, demonstrated the importance of temporal control over NF 
delivery in promoting successful nerve regeneration [16]. 
In Chapters 2 and 3, we discussed the importance of Schwann cells in nerve 
regeneration and the development of gradient generation and cell migration and analysis 
platforms, which provided significant insight into the topographical and biochemical 
gradient cues necessary for promoting directional Schwann cell guidance. Human 
Schwann cells exhibited rapid migration on 1.2 µm diameter, aligned electrospun fibers, 
and we demonstrated the significant effects of concentration and gradient steepness on the 
efficacy of GDNF gradients in promoting directional Schwann cell migration. Therefore, 
we hypothesize that developing an NGC which incorporates both topographical and 
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biochemical gradient guidance will promote improved axon and Schwann cell migration 
into nerve injury gaps and increase the regenerative outcomes of peripheral nerve injuries 
compared to NGCs with uniform spatial NF distribution. Incorporating aligned fibers into 
the lumen of the conduit would provide a suitable upon which regenerating nerve tissue 
can grow [4]. Delivery of NFs in a gradient instead of uniformly distributed throughout a 
conduit will enhance bridging of nerve across the entirety of the nerve gap by increasing 
Schwann cell infiltration of the nerve gap, encouraging complete extension of regenerating 
neurons across the nerve gap [3], and preventing the prevalence of the “candy store” effect 
which occurs in uniform NF delivery [4] or with excessive NF overexpression [16-18]. An 
NGC such as this would provide great potential for enhancing the regeneration of large gap 
nerve injuries in which regeneration of nerve tissue across the entirety of the nerve injury 
gap is generally poor. 
In this chapter, we first discussed the development of NGC technologies which are 
capable of topographical and biochemical guidance (Table 4.1). We then demonstrated 
that delivery of NFs in the form of a gradient substantially improved axonal ingrowth into 
short-gap nerve injuries within the first month of regeneration. Moreover, we demonstrated 
a steepness-dependent response in which only the steep gradient condition elicited 
substantial improvement in nerve regeneration, enhancing axon growth and functional 
recovery. We also showed that delivery of GDNF gradients in our combinatorial NGCs 
increases axonal growth into large injury gaps and improves complete regeneration of 
axons across the nerve gaps compared to NGCs with uniform GDNF delivery. Finally, we 
demonstrated that functional recovery in NGCs containing GDNF gradients resulted in 
functional values similar to values measured in a normal nerve before operation, indicating 
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that GDNF gradient delivery enhanced the maturity of neuron-glial interactions and 
promoted substantial functional recovery. 
 Methods 
4.2.1 Electrospinning and preparation of S-Shaped nerve guide 
Nerve guides incorporating both topographical and biochemical guidance were 
produced using modification of an S-shaped conduit design first developed by Andrew 
Hurtado [19]. Electrospinning was performed as described in chapter 2 and previous work 
[20]. Briefly, a solution of 8%w/w PCL (molecular weight of 80k, Sigma) in a solvent of 
90%w/w DCM and 10%w/w DMF is electrospun at 5 mL/h through a 27-gauge needle at 
a distance of 11 cm from the face of a 40 cm-diameter wheel rotating at 70 rpm with a 13 
kV positive voltage. The apparatus was rastered across the face of the wheel using a 
programmable linear stage (Newmark Systems), repeatedly moving over a distance of 75 
mm at 0.1 mm/sec for 2 h. The nanofiber mat was partially melted to increase strength by 
heating with a hair dryer for 5 sec to create a mechanically strong film. Aligned PCL 
nanofibers were then electrospun directly onto the film, by spinning 12%w/w PCL in 
Chloroform at a flowrate of 0.6mL/hr and +8kV voltage 6cm from the wheel surface, 
rotating at 750rpm. The aligned fibers were spun for 12 passes at 0.1 mm/sec for travel 
distance of 70 mm. The conduit outer wall was electrospun with the 8 w/w% PCL in 
DCM/DMF solution at a flow rate of 0.75 mL/h through a 27-gauge needle 6 cm onto a 
rotating 1.5 mm steel mandrel. A 7.5 kV positive voltage is applied to the needle tip, while 
a 2.5 kV negative voltage is applied to the mandrel, spinning over a distance of 23 cm for 
70 passes at 5 mm/sec. The tubes were then lyophilized for 48 h to remove residual solvent, 
then heat-treated to increase strength by soaking in hot water, 20 minutes subsequently at 
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each of 50°C, 54°C, and 56°C. The tubes were then cut to 10mm segments and sterilized. 
The aligned nanofiber sheets and nanofiber outer walls were sterilized via ethylene oxide 
sterilization. 
4.2.2 Gradient hydrogels for nerve guidance conduits 
Hydrogels containing GDNF gradients were prepared using a 1-cm gradient 
channel (4.5 µL channel volume) and cut to 7 mm in length after gradient generation. All 
groups with GDNF contained 600 ng of GDNF in the final 7 mm hydrogel strip. Uniform 
GDNF was loaded at 190 µg/mL. To generate the shallow gradient, 4.5 µL of 95.2 µg/mL 
GDNF was preloaded into channel and 1.5 µL of 200 µg/mL GDNF was added at the inlet. 
Steep gradient hydrogels were generated by adding 1.5 µL of 400 µg/mL GDNF solution 
onto the inlet of a pre-filled channel containing no GDNF. The gradient gels were placed 
between two layers of aligned nanofibers, which were then wrapped around two 500-μm 
steel mandrels to form the S-shape seen in Figure 3.3. The wrapped sheets were then 
inserted into the lumen of the 10mm-long electrospun outer tube, and the mandrels are 
carefully removed. The sheets were oriented so that fibers were aligned longitudinally 
along the nerve guide. 
4.2.3 Sciatic nerve transection and repair in rats 
All animal surgeries and evaluation of the outcome of the nerve repair were carried 
out according to protocols approved by the Johns Hopkins Institutional Animal Care and 
Use Committee. The surgeries were performed on adult male Sprague-Dawley rats (200 – 
300 g). Following isoflurane anesthetization, the sciatic nerve in the left leg was exposed 
through a mid-thigh incision. The nerve guidance conduits were pre-wetted by soaking in 
sterile PBS. Nerve defects were then repaired with no-GDNF NGCs (control, N = 7), 
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shallow GDNF gradient NGCs (N = 8), steep GDNF gradient NGCs (N = 5) and uniform 
GDNF NGCs (N = 7). GDNF-loaded NGCs contained 600 ng total GDNF for all 
conduits.5mm of the nerve was resected, and each end of the nerve was inserted 1.5 mm 
into the nerve guidance conduit to leave a gap of 7 mm between the nerve ends. The nerve 
ends were sutured in place via 10 – 0 nylon sutures (Ethicon). The surgical site was closed 
with wound clips, and 0.1 mg/kg of buprenorphine was injected for pain management. The 
animals were allowed free access to food and water and were regularly monitored.  
4.2.4 Electrophysiology assessments in rat model 
One month post-surgery, the compound motor action potentials were recorded 
according to standard protocols using LabChart (AD Instruments) [4]. The stimulating 
needle electrodes were inserted into the sciatic notch, proximal to the nerve guide. The 
recording electrodes were placed into the ankle, at a distance of 7.2 cm +/- 0.3 mm from 
the stimulating electrodes.  
4.2.5 Harvesting of regenerated nerves in rat model 
Following electrophysiology testing (1 month post-surgery), the rats were 
euthanized. The nerve guide and surrounding nerve was removed and fixed in 4% 
Paraformaldehyde. After 24 h at 4°C, the middle segment of the nerve guide (2.5-5.5 mm 
from proximal nerve stump) was resected and fixed for a further 24 h at 4°C in 4% 
paraformaldehyde and 3% glutaraldehyde. The tissue was mounted in embedding resin, 
sectioned, and stained with toluidine blue [4]. 
4.2.6 Canine model protocol overview 
All animal studies were performed according to the protocol approved by the 
Animal Care and Use Committee and in accordance with the Animal Care Policies of Johns 
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Hopkins University. Twenty three healthy adult beagle canines weighing 9.0–13 kg were 
included in this study. All surgical procedures were performed in accordance with the 
“Guide for the Care and Use of Laboratory Animals” published by the National Institutes 
of Health. The experimental protocol was approved by the Animal Care and Use 
Committee (ACUC) of Johns Hopkins University, and all efforts were made to minimize 
animal suffering. Fasting was imposed on all canines for 24 h prior to the operation, but 
canines were given drinking water ad libitum. 
4.2.7 Preparation of NGCs for canine model 
NGCs were prepared identically to the previous rat S-design NGCs, with variations 
to the size of the conduit and length of gradients generated to accommodate increased larger 
diameter of nerve in canine model and increased length of nerve gap (20 mm gap length). 
The inner diameter of the conduit was increase from 1.5 mm for the rat model to 2.0 mm 
for the canine model. The conduits were made to be 22 mm in length, so that 1 mm of each 
nerve end can be inserted into the NGC for suturing, leaving a 20 mm gap for the nerve to 
regenerate. Aligned fiber sheets were cut into 20 mm long segments to bridge this gap. 
Hydrogel sheets were generated in 1 cm long gradient channels, with two 1 cm long 
hydrogels being placed end-to-end in each conduit, such that a total GDNF loading of 600 
ng per tube was achieved for the uniform-loading and gradient groups. 
4.2.8 Canine peroneal nerve injury surgery preparation 
All surgical procedures and physiological measurements were performed under 
general anesthesia. The animals were premedicated by intramuscular administration of 
10mg/kg Ketamin and 0.005-0.01 mg/kg Buprenorphine. They were then anesthetized 
with isoflurane under mechanical ventilation. Continuous monitoring was performed by 
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electrocardiography and oxygen saturation by reflectance oximetry using a sensor clipped 
to the ear. The lateral hind-limb region was shaved and the animals were positioned in the 
lateral position. The hind-limb region was disinfected with 70% ethanol and iodine 
tincture, and covered with sterilized drapes.  
4.2.9 Canine peroneal nerve injury surgical procedure 
The healthy beagles were deeply anesthetized using isoflurane throughout the 
surgical procedure. Surgery was performed on the canine’s hind-limb under aseptic 
conditions. For nerve conduit implantation, the superficial peroneal nerve was exposed 
by an incision in lateral leg, overlying muscles were separated by traction and 15 mm of 
the nerve was resected out to result in a 20-mm defect gap. Nerve defects were then 
repaired with no-GDNF NGCs (control, N = 10), GDNF gradient NGCs (N = 10), and 
uniform GDNF NGCs (N = 10). GDNF-loaded NGCs contained 600 ng total GDNF for 
all conduits. All nerve conduits (length = 20 mm) were filled with 15 µl of PBS prior to 
implantation. Next, the proximal and distal stumps were sutured to the conduit using a 
10–0 nylon monofilament. For autograft implantation (N = 10), a 20 mm superficial 
peroneal nerve was transected and reverse transposed into the gap. Both ends were then 
sutured using 10–0 strings. The incision was then closed using 4-0 absorbable braided 
suture in a subcuticular pattern, and 3-0 absorbable braided suture in a skin pattern. The 
canines were monitored and given 2 additional dose of Buprenorphine (0.005-0,01mg/kg, 
IM) in the evening after surgery and the following morning. For the post-operative care, 
the canines were monitored daily for three days following surgery, then 2-3 days for the 
first month, and then weekly until the end of the study. The animals were kept in 
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temperature (28°C) and humidity (45%) controlled rooms with 12 h light cycles and 
allowed free access to food and water. 
4.2.10 Electrophysiology assessments in canine model 
Six months after surgery, compound nerve action potential (CNAP) responses were 
used to evaluate electrophysiological recovery prior to harvesting the distal nerve and nerve 
conduits. After anesthetization with isoflurane under mechanical ventilation, superficial 
peroneal nerve with transplantation of nerve conduits was dissected free from connective 
tissue and prepared for electrophysiology test. The stimulating electrodes were placed at 
the proximal end of superficial peroneal nerve, 5 mm from the proximal end of nerve 
conduits, while the recording electrodes were placed at the distal end of superficial 
peroneal nerve, 5 mm to the distal end of nerve conduits to record the CNAP values. 
CNAPs were elicited with a stimulation of 1.00 ms delay, 0.10 ms duration with amplitude 
voltage ramped from 1 to 5 v.  Individual CNAPs were recorded at each step of the ramp.  
4.2.11 Harvesting of regenerated nerves in canine model 
The superficial peroneal nerve with nerve guide or autograft stump was resected 
for histologic analyses after electrophysiology test.  All other pre-operation, intra-
operation and post-operation protocols were the same as described in the nerve guide 
implantation surgical procedure. After 24 h at 4°C, the middle segment of the nerve guide 
and segment of nerve 3 mm distal to the nerve guide were resected and fixed for a further 
24 h at 4°C in 4% paraformaldehyde and 3% glutaraldehyde. The tissue was mounted in 
embedding resin, sectioned, and stained with toluidine blue [4]. 
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4.2.12 Histomorphometric analysis 
Imaging of the fixed nerve sections was conducted using an inverted microscope 
(Nikon) at 10× and 63× magnification. Total nerve tissue area was measured at 10×. Nerve 
count was measured at 63× by averaging the axon count within 5-8 randomized images 
within each sample nerve area and calculating total nerve count and nerve density using 
the measured nerve tissue area. 
4.2.13 Statistical analysis 
Axon counts, axon densities, and nerve area measurements are represented by mean 
± Standard Error. Electrophysiology measurements are represented by mean ± Standard 
Deviation. Statistical comparisons were conducted using ANOVA with Tukey’s post-hoc 
HSD test. Differences were considered statistically significant for p < 0.05. 
 Results and Discussion 
4.3.1 Nerve Guidance Conduit Design 
Multiple generations of NGC designs incorporating NF delivery and topographical 
guidance have been developed by our labs, as seen in Table 4.1. The latest iteration, the S-
shaped conduit, was found to be the most effective in promoting nerve ingrowth, providing 
an optimal combination of aligned fiber surface area and luminal space for tissue ingrowth. 
This method was first developed by Hurtado et al. [19] and was designed as a method for 
increasing fiber surface area compared to open-lumen designs. We have adopted this 
conduit design for this study. Modification of the conduit fabrication process allowed for 
incorporation of gradient-delivery hydrogel sheets between layers of the fiber sheets 
(Figure 4.1a). By placing a gelatin hydrogel sheet loaded with a predetermined GDNF 
gradient between two adjacent aligned fiber layers (Figure 4.1b), the gradient-releasing 
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feature can be incorporated into the NGC with an S-shaped cross-section insert in the 
conduit (Figure 4.1c). This modular design allows for separate production of the aligned 
fiber sheets and gradients, providing the ability to independently tailor both the 
topographical cues and biochemical guidance to the desired length, fiber diameter, NGC 
diameter, and gradient characteristics. 
4.3.2 Non-critical injury gap model for study of acute nerve regeneration 
Two nerve injury models were selected for the investigation of the effect of GDNF 
gradient delivery. The first injury model was a non-critical gap (7-mm injury), acute rat 
sciatic nerve regeneration model. The primary purpose of this model was to determine if 
the mode of delivery of GDNF (i.e. gradient vs. uniform) affected the acute regeneration 
(i.e. regeneration within 1 month) of axons into our combinatorial NGCs to determine 
which GDNF delivery configuration was most effective in promoting rapid nerve regrowth 
during the early phase nerve repair. The results of the acute regeneration model were also 
used to select the most effective gradient condition for use in the large gap (20 mm), long-
term regeneration (7 month recovery) model to be conducted in canines. In Chapter 3, we 
demonstrated that gradient steepness played an important role in the efficacy of GDNF 
gradient guidance of human Schwann cell migration. We demonstrated that for gradients 
of equivalent total GDNF loading, the migration rate and directional bias of Schwann cells 
were dependent on the steepness of the gradient to which they were exposed. Therefore, 
we elected to compare two gradient conditions for which the total GDNF loading was 
equivalent, but for which the gradient steepness varied significantly in order to elucidate 




To investigate acute nerve regeneration, all nerve grafts were harvested 4 weeks 
after implantation. Histological analysis on the mid-graft sections shows that GDNF 
delivery, both in uniform and gradient configurations, improves the ingrowth of myelinated 
axons into the midpoint of the conduit compared to conduits without GDNF (Figure 
4.2a,b) by significantly increasing the area of functional nerve tissue regenerated into the 
lesion site (Figure 4.2b). Additionally, the delivery of GDNF in the steepest gradient 
further improves the axonal density and ingrowth and compared to other delivery 
configurations, providing significantly higher myelinated axon counts (4045.6 ± 1101.8 
axons per nerve) compared to that of the shallow GDNF gradient (2084.9 ± 554.6 axons 
per nerve) or uniform GDNF (1610.3 ± 626.1 axons per nerve) (Figure 4.3). This result 
indicates that the effect of gradient delivery is highly dependent on the concentration range 
and steepness of the gradient being delivered, but that delivery of selective gradient 
conditions can be effective in directing nerve growth across lesion gaps. 
Although the histomorphometric analysis was conducted at a short 4-week time 
point, EMG data exhibited impressive, albeit heterogeneous, functional recovery in the 
steep GDNF gradient group (Figure 4.4). Even after only one month of recovery, 
significant nerve function recovery was found in the steep GDNF gradient group. 
Additionally, the data revealed that the shallow GDNF gradient, while promoting adequate 
axonal ingrowth, exhibited markedly poorer nerve function, instead resulting in function 
comparable to that of the uniform GDNF group. These data indicate the shallow gradient 
suffered from similar axon trapping seen in NGCs delivering uniform GDNF [4], for which 
axon regrowth is significant but functional recovery is poor due to regenerating axons 
becoming entrapped within the NGC and unable to reinnervate the distal nerve stump. 
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These results emphasize the importance of gradient steepness in the ability for nerves to 
sense and respond to the presence of NF gradients. In this experiment, although both 
gradient groups contained the same amount of GDNF, the most pronounced improvement 
in nerve regrowth was seen in the steepest gradient configuration, which further 
strengthened the results we found in Chapter 3 demonstrating that gradient steepness plays 
an important role in the migratory and chemotropic activity of Schwann cells to gradients 
containing similar levels of NFs. The design of this NGC provides NF delivery localized 
to the lesion site, but by enhancing nerve growth across the entirety of the nerve gap and 
maximizing the number of axons successfully reinnervating the distal nerve, NF gradient 
delivery in NGCs can markedly improve the functional regeneration following peripheral 
nerve injuries. These results suggest that previous attempts to incorporate NF gradients into 
NGCs to enhance nerve regeneration may have been limited in their regenerative potential 
by using non-optimized NF concentration range and gradient steepness conditions, as well 
as suffering from their use of sensory-specific NFs [3]. While we were limited in the 
number of gradient groups tested in this experiment, the significant improvement in 
recovery exhibited by the steep gradient condition demonstrated the potential for NF 
gradients in enhancing peripheral nerve regeneration and was instrumental in the selection 
of design of future large animal (canine) experiments. 
4.3.3 Large gap injury, long-term nerve regeneration model 
In order to elucidate the effects of gradient delivery in long-term regeneration of a 
critical-gap injury, we developed a large-gap canine peripheral nerve injury model for 
investigating the efficacy of NGCs delivering NF gradients and topographical guidance in 
long-term peripheral nerve regeneration. A canine nerve injury model exhibits several 
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benefits compared to a rat nerve injury model. First, a canine model allows us to repair 
larger diameter nerves than are available in the rat model that are closer to the nerve 
diameters of human nerves. Second, because canines are of significantly larger anatomical 
size compared to rats, the canine model has greater potential for testing longer injury gaps 
than what is capable for rats [21], and therefore is a more suitable model for large gap 
injuries where gradient guidance may be necessary to promote complete regeneration 
across the length of the injury gap. Finally, because of their larger size, canines better 
potential model animals for peripheral nerve injuries in which the injury occurs significant 
distances from the target muscle or sensory innervation site, where regenerating nerves 
must bridge an injury gap and subsequently traverse large distances of distal nerve to reach 
the reinnervation targets. Long-term, long-distance injury models in rats are limited by 
their comparatively small anatomical size.  
In contrast to the short gap, one-month rat nerve repair model, the canine study was 
designed to elucidate how NGC-delivered NF gradients influence large gap, long-term 
nerve recovery. For this study, we reconfigured the S-shaped conduit to bridge a larger 
injury gap (20 mm), a length which is larger than the critical gap of the more commonly-
used rat model [21]. The critical gap of a canine nerve is less known, but using the known 
critical gap for rats, an animal which exhibits significantly greater regeneration potential 
than humans and other species [21], provides an adequate estimate for the larger canine 
model.  NGCs were implanted into a canine peroneal nerve injury model, which was 
selected due to its ease of access for surgical implantation, mixed population of motor and 
sensory neurons, and ease of electrophysiological testing. Additionally, because canine 
models require adoption of the animal after all experimental procedures have been 
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completed, ethical issues can arise if the canines exhibit significant, permanent functional 
deficits following experimentation. The sacrifice of the peroneal nerve limits the functional 
loss of the animal, especially compared to models which sacrifice the sciatic nerve, a much 
larger nerve which innervates a significantly larger portion of the canine hind limb. As 
such, we are able to obtain a significant amount of information regarding the effect of our 
NGCs in the regeneration of the canine peroneal nerve without substantially reducing the 
quality of life of the animal after studies have been completed. 
For the canine large gap study, four experimental groups were compared to 
determine the effect of GDNF gradient delivery on large gap, long-term nerve repair 
compared to no GDNF, uniform GDNF, and autograft. Initial investigation of the gross 
histological sections elicited notable differences between the morphology of the nerve 
sections in the NGCs compared to the normal nerve and autograft (Figure 4.5). The canine 
peroneal nerve consists of four nerve fascicles, as indicated by the morphology of the mid-
graft image of the autograft (Figure 4.5a) and distal nerve images for all four experimental 
groups (Figure 4.5e-h), contrasted with the two large luminal spaces available in the S-
shaped NGCs (Figure 4.5b-d). The area of the lumens in the NGCs were, by comparison, 
significantly larger than the area of the nerve fascicles in the peroneal nerve, and generally 
had a much higher area of tissue ingrowth in the NGCs compared to that of the fascicles in 
the autograft and distal nerve. However, upon closer inspection of the nerve areas, much 
of the tissue in the NGCs consisted of fibrous tissue closely associated with the PCL fibers, 
which remained intact 7 months post-implantation (Figure 4.6a,b). Axonal growth was 
not present in the fibrous tissue, but rather was localized to small fascicles within the 
fibrous tissue (Figure 4.6a) or in larger regions where fibers were not present (Figure 
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4.6b). The presence of fibrous tissue in the NGC groups reduced the total nerve area in 
which myelinated neurons were present compared to that of the autograft (Figure 4.7), 
both in the middle of the nerve graft as well as in the tissue distal to the nerve graft. This 
result indicates that the aligned fibers provide a highly suitable substrate for fibroblasts, 
which compete with nerve tissue for growth into the NGCs.  Future NGC designs should 
utilize chemical or physical modifications to limit the amount of fibrous tissue production 
in order to increase potential functional nerve tissue ingrowth. 
Although the nerve areas across all three NGC groups were comparable (Figure 
4.7), it was evident that delivery of GDNF gradients in the NGCs increased the density of 
myelinated axons (Figure 4.8) growing into the nerve graft and into the distal nerve stump 
(Figure 4.9). GDNF gradient delivery increased the number of myelinated axons growing 
into the nerve graft, with an average axon count of 1675 ± 325 axons per nerve, compared 
to that of the no GDNF NGCs (494 ± 127 axons per nerve) and uniform GDNF (1043 ± 286 
axons per nerve). Additionally, GDNF gradient delivery improved the number of axons, 
which successfully bridged the entire 20-mm gap into the distal stump (970 ± 105 axons 
per nerve), compared to no GDNF (326 ± 86 axons per nerve) and uniform GDNF NGCs 
(578 ± 128 axons per nerve) (Figure 4.10). These results confirmed that over a larger gap, 
the gradient delivery of GDNF was the most effective method in promoting axonal growth 
across the entirety of a nerve gap. An optimized gradient GDNF delivery, i.e. with a steeper 
gradient, improved axonal growth into the conduit and across the gap to reinnervate the 
distal stump. 
The effectiveness of gradient delivery is further indicated by the recovery of nerve 
function after 7 months. Nerve EMG was recorded prior to nerve harvest and compared to 
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pre-surgical values. Animals with the GDNF gradient delivery exhibited signal latency 
values, both onset and peak, similar to that of pre-surgical values (Figures 4.11 and 4.12), 
an indication of the presence of mature, myelinated neurons. Additionally, signal amplitude 
was improved in both the uniform GDNF and gradient GDNF groups to levels comparable 
to pre-surgical values (Figures 4.13 and 4.14). Interestingly, the GDNF gradient group 
exhibited better functional recovery than the autograft groups, in spite of having lower 
nerve area and axon numbers. These data suggest that while the autograft promoted a 
higher number of axons to bridge the nerve gap, the delivery of GDNF as a gradient may 
have improved the maturation and function of the neurons, which reinnervated the distal 
stump, resulting in improved signal transduction and functional recovery. While limitations 
in the NGC design may have reduced its efficacy in the large animal model, the 
histomorphometric and functional data provide strong evidence that optimization of NF 
gradient delivery is an important approach for improving nerve regeneration in both small 
gap and large gap repairs in peripheral nerve injuries.  
 Conclusions 
We have successfully developed a NGC, which combines topographical and 
biochemical gradient guidance for the improvement of peripheral nerve regeneration. In a 
short gap repair model in rat, we demonstrated the importance of gradient steepness in 
promoting nerve regeneration, with the steepest gradient group promoting the highest 
degree of axonal regeneration and functional recovery. This gradient condition was then 
translated to a large gap repair model in beagles to determine if gradients were capable of 
improving regeneration across a larger gap. Our results demonstrated that the specific 
configuration of the GDNF gradient delivered in an NGC significantly influenced the 
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regeneration of axons across the entirety of a large nerve gap. Although our NGC design 
exhibited fibrous tissue ingrowth, which competed with growth of nerve tissue, the NGCs 
delivering gradients of GDNF improved the functional recovery of the large gap injuries 
and resulted in functional outcomes that were comparable to pre-surgical values. Future 
studies will aim to further optimize the gradient profiles and NGC designs in order to better 








Table 4.1: Generations of conduit designs incorporating aligned fiber topographical 






Figure 4.1: Fabrication of S-shaped conduit containing aligned 
fiber topography and hydrogel-based NF gradient delivery. (a) 
Gradient-containing hydrogels placed between aligned fiber sheets 
and rolled into S-shaped conduit. (b) Aligned fibers with average 
diameter of 1.2 µm. Scale bar is 10 µm. (c) Scanning electron 





Figure 4.2: Histomorphometry of small gap, acute regeneration rat 
sciatic nerve injury model (N > 5). (a) Representative images of 
nerve cross sections obtained using 63x objective. Scale bars are 
10 µm. (b) Average nerve area of different NGC groups. Error bars 
represent Standard Deviation. Differences considered statistically 





Figure 4.3: Average axon count of different NGC groups in small 
gap, acute regeneration rat sciatic nerve injury model (N > 5). Error 





Figure 4.4: Electrophysiological measurement of different NGC 
groups in small gap, acute regeneration rat sciatic nerve injury 





Figure 4.5: Histological cross-sections of nerves of different NGC groups in 
large gap, long-term regeneration canine peroneal nerve injury model. (a) Mid-
graft of autograft control. (b) 3-mm distal to autograft control. (c) Mid-graft of 
no-GDNF S-shaped NGC. (d) 3-mm distal to no-GDNF S-shaped NGC. (e) 
Mid-graft of uniform GDNF S-shaped NGC. (f) 3-mm distal to uniform GDNF 
S-shaped NGC. (g) Mid-graft of gradient GDNF S-shaped NGC. (h) 3-mm distal 
to gradient GDNF S-shaped NGC. Images obtained with 2.5x objective. Scale 





Figure 4.6: Histology of nerve regions showing that PCL fibers remain 7 
months after implantation. Fibers (white dots, red arrows) are surrounded by 
fibrotic tissue, whereas nerve tissue is localized in regions where fibers are not 
present (tissue border noted by red line). Images obtained with 63x objective. 





Figure 4.7: Average nerve area of different NGC groups in large gap, long-term 
regeneration canine peroneal nerve injury model (N >5). Error bars represent 





Figure 4.8: Representative histological cross-sections of nerves of different 
NGC groups in large gap, long-term regeneration canine peroneal nerve injury 
model. (a) Mid-graft No-GDNF S-shaped NGC. (b) Mid-graft uniform GDNF 
S-shaped NGC. (b) Mid-graft gradient GDNF S-shaped NGC. Images obtained 





Figure 4.9: Average nerve density of different NGC groups in large 
gap, long-term regeneration canine peroneal nerve injury model (N 
> 5). Error bars represent Standard Error. Differences considered 





Figure 4.10: Average total axon count of different NGC groups in 
large gap, long-term regeneration canine peroneal nerve injury 
model (N > 5). Error bars represent Standard Error. Differences 





Figure 4.11: Average onset latency of different NGC groups in large 
gap, long-term regeneration canine peroneal nerve injury model, 
measured with CNAP (N = 10). Error bars represent Standard 






Figure 4.12: Average peak latency of different NGC groups in large 
gap, long-term regeneration canine peroneal nerve injury model, 
measured with CNAP (N = 10). Error bars represent Standard 






Figure 4.13: Average signal amplitude of different NGC groups in 
large gap, long-term regeneration canine peroneal nerve injury 
model, measured with CNAP (N = 10). Error bars represent Standard 






Figure 4.14: Average peak area of different NGC groups in large 
gap, long-term regeneration canine peroneal nerve injury model, 
measured with CNAP (N = 10). Error bars represent Standard 
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Chapter 5 : Conclusions and future directions for NF gradient-
guided nerve regeneration         
5.1 Conclusions 
In this thesis, we have developed multiple gradient generation and delivery 
platforms capable of tailorable, controllable gradient generation for in vitro and in vivo NF 
gradient delivery. By developing gradient generation techniques capable of establishing 
well-controlled, centimeter-scale gradients which can be scaled for rapid gradient 
production, we successfully overcame limitations of prior gradient generation techniques 
which were restricted to either in vitro or in vivo gradient delivery. Through use of a rapid, 
convection-driven gradient technique, hydrogel films could be generated which 
encapsulated and delivered centimeter-length gradients, and controlled the release rate of 
NF gradients through the incorporation of methacrylated heparin into the hydrogel film. A 
diffusion-based gradient generation platform was developed for flow-free gradient 
generation for in live-cell migration guidance. The technique was also utilized to 
functionalize a variety of hydrogel materials and was used to begin elucidating the effects 
of different NF gradients on the guidance of motor and sensory neuron outgrowth. 
Furthermore, we combined hydrogel-based NF gradient delivery with aligned nanofiber 
topographical guidance in a novel live-cell imaging and migration analysis platform to 
examine the effect of nanofiber diameter on human Schwann cell migration, demonstrate 
the efficacy of GDNF as a chemoattractant for human Schwann cells, and determine the 
influence of modulating gradient characteristics, particularly gradient concentration range 
and steepness, in the guidance of Schwann cell migration. Finally, we translated the 
hydrogel-based NF gradient generation platform into a NGC, which combined 
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topographical and biochemical gradient guidance, and demonstrated the effectiveness of 
delivering NF gradients in the enhancement of peripheral nerve regeneration and functional 
recovery in in vivo acute, short-gap injuries and large-gap injury models. The ability to 
effectively utilize these gradient generation platforms in both in vitro and in vivo nerve 
guidance applications provides significant value to the field of nerve regeneration. These 
methods are promising tools for elucidating the mechanisms underlying directed Schwann 
cell and neuronal guidance, the knowledge of which can be used to design the next 
generation of nerve guided capable of enhancing regeneration of severe peripheral nerve 
injuries. 
5.2 Future Directions 
While currently available nerve regeneration conduits and techniques have resulted 
in adequate axonal regeneration, the axonal regeneration does not always result in 
significant functional recovery [1]. One of the prevailing factors resulting in the 
discrepancy between promoting axonal growth and enhancing functional outcomes is due 
to improper reinnervation of motor and sensory targets. Peripheral nerves often consist of 
a mixture of motor and sensory neurons. In injuries that result in disruption of nerve 
continuity, axon regeneration is often misdirected resulting in axons innervating improper 
targets [2, 3]. Without proper axon guidance and repair, motor axons may improperly reach 
sensory targets or sensory neurons may reach motor targets, causing poor functional 
recovery resulting from the inability for axons to reach proper reinnervation target organs. 
Thus, it is important to develop new nerve guidance platforms, which are capable of 
enhancing the spatial guidance of specific neuronal populations to increase proper 
reinnervation and maximize functional recovery. 
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Neurons have been shown to exhibit motor- and sensory-specificity in axonal 
outgrowth and chemotropism in response to different types of NFs [1]. Höke et. al. have 
demonstrated that following peripheral nerve injury, growth factor expression differs in 
Schwann cells within motor-associated and sensory-associated nerves [4]. NGF, which is 
upregulated in sensory-associated Schwann cells following axonal injury, has been shown 
to act specifically on small primary sensory and sympathetic neurons. While it has been 
shown to promote chemotaxis of sympathetic [5] and dorsal root ganglion neurons [6-9], 
the chemotropic activity of motor neurons towards NGF is limited. GDNF is substantially 
upregulated in motor nerves after injury [4] and has been shown to dramatically improve 
the survival of motor neurons [10, 11] as well as sensory neurons [11]. PTN, which is also 
substantially upregulated in motor nerves after injury [4], exhibits mostly motor-specific 
guidance and regeneration [1, 12]. These inherent differences in motor and sensory 
neuronal chemotaxis in response to different NFs can potentially be exploited to promote 
motor-specific or sensory-specific nerve regeneration in vivo. 
The numerous gradient generation and delivery platforms developed in this thesis 
may provide significant insight into the utilization of NF delivery as a method for 
promoting nerve-specific guidance. With our gradient generation platforms, we are capable 
of examining the migration guidance of a variety of neuronal and glial populations, 
utilizing the tailorability and controllability of our gradient platforms for investigating the 
effects of different NFs in guiding migration of separate populations of cells. Our 
preliminary studies have been investigating the use of our hydrogel-based gradient delivery 
platforms for motor- versus sensory-specific guidance on collagen hydrogels 
functionalized with gradients of different NF type and gradient characteristics in motor and 
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sensory nerve organotypic models. Additionally, we are working to develop divergent 
gradient systems with which we can examine the use of divergent gradients of neuron-
specific NFs in separating mixed populations of motor and sensory neurons into organized, 
separate motor and sensory paths. These models will potentially uncover new insights into 
how to promote outgrowth of motor and sensory neuron populations along separate spatial 
paths. Such insights would be instrumental in the design of new generations of nerve guides 
capable of improving functional outcomes by better retaining the spatial organization of 
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Mentoring Experience 
Johns Hopkins Undergraduates 
Andrew Han Materials Science and Engineering Sept. 2015-Mar. 2016 
Kalina Martinova Materials Science and Engineering Aug. 2015-Mar. 2016 
Ashish Aman Biomedical Engineering Jun. 2015-Mar. 2016 
Clay Andrews Biomedical Engineering Sept. 2014-Aug. 2015 
Letitia Chim Materials Science and Engineering Jun. 2013-May 2015 
John DiCapua Materials Science and Engineering Mar. 2013-May 2015 
 
Institute for Nanobiotechnology Summer Research Experience for Undergraduates 
Cameron Nemeth University of Washington Jun. 2013-Aug. 2013 
Lauren Lee Cornell University Jun. 2012-Aug. 2012 




Women in Science and Engineering Mentoring Program 
High school student 
mentees 
Baltimore-area high schools Sept. 2011-Jan. 2012 
 
Teaching Experience 
Cell and Tissue Engineering Lab 580.452 Spring 2013 
• Purchased and organized lab materials 
• Assisted students during lab sessions 
• Compiled and graded final exam 
• Managed course website and coordinated with course instructors 
 
Johns Hopkins January Intersessions- Course Instructor                             January 2013 
• “Great Experiments in Science and Medicine” (AS.250.113.13.IN13) 
• Designed lectures discussing major discoveries in the field of medicine 
• Prepared and presented 6 lectures for bi-weekly, one month course for 14 students. 
• Coordinated guest lectures from numerous Hopkins faculty 
• Prepared homework and exams based on lecture materials 
 
Johns Hopkins January Intersessions- Course Instructor                             January 2012 
• “The Science and Medicine of the Nobel” (AS.250.113.13.IN12) 
• Designed lectures discussing major discoveries of Nobel Prize winners in the fields of 
medicine, chemistry, and physics 
• Prepared and presented 6 lectures for bi-weekly, one month course for 14 students. 
• Coordinated guest lectures from numerous Hopkins faculty 
• Prepared homework and exams based on lecture materials 
 
 
